id	sid	tid	token	lemma	pos
ecj-13710	1	1	hrev_master	hrev_master	NOUN
ecj-13710	2	1	[	[	X
ecj-13710	2	2	page	page	NOUN
ecj-13710	2	3	30	30	NUM
ecj-13710	2	4	]	]	PUNCT
ecj-13710	3	1	[	[	X
ecj-13710	3	2	emergency	emergency	NOUN
ecj-13710	3	3	care	care	NOUN
ecj-13710	3	4	journal	journal	NOUN
ecj-13710	3	5	2025	2025	NUM
ecj-13710	3	6	;	;	PUNCT
ecj-13710	3	7	21:13710	21:13710	NUM
ecj-13710	3	8	]	]	X
ecj-13710	3	9	emergency	emergency	NOUN
ecj-13710	3	10	care	care	NOUN
ecj-13710	3	11	journal	journal	PROPN
ecj-13710	3	12	2025	2025	NUM
ecj-13710	3	13	volume	volume	NOUN
ecj-13710	3	14	21:13710	21:13710	NUM
ecj-13710	3	15	abstract	abstract	ADJ
ecj-13710	3	16	hyperkalemia	hyperkalemia	NOUN
ecj-13710	3	17	is	be	AUX
ecj-13710	3	18	a	a	DET
ecj-13710	3	19	common	common	ADJ
ecj-13710	3	20	electrolyte	electrolyte	ADJ
ecj-13710	3	21	disturbance	disturbance	NOUN
ecj-13710	3	22	in	in	ADP
ecj-13710	3	23	hospitalized	hospitalize	VERB
ecj-13710	3	24	patients	patient	NOUN
ecj-13710	3	25	,	,	PUNCT
ecj-13710	3	26	often	often	ADV
ecj-13710	3	27	caused	cause	VERB
ecj-13710	3	28	by	by	ADP
ecj-13710	3	29	impaired	impaired	ADJ
ecj-13710	3	30	renal	renal	ADJ
ecj-13710	3	31	potassium	potassium	NOUN
ecj-13710	3	32	excretion	excretion	NOUN
ecj-13710	3	33	due	due	ADP
ecj-13710	3	34	to	to	ADP
ecj-13710	3	35	hypoaldosteronism	hypoaldosteronism	NOUN
ecj-13710	3	36	.	.	PUNCT
ecj-13710	4	1	type	type	NOUN
ecj-13710	4	2	4	4	NUM
ecj-13710	4	3	renal	renal	ADJ
ecj-13710	4	4	tubular	tubular	ADJ
ecj-13710	4	5	acidosis	acidosis	NOUN
ecj-13710	4	6	(	(	PUNCT
ecj-13710	4	7	rta	rta	PROPN
ecj-13710	4	8	)	)	PUNCT
ecj-13710	4	9	,	,	PUNCT
ecj-13710	4	10	commonly	commonly	ADV
ecj-13710	4	11	associated	associate	VERB
ecj-13710	4	12	with	with	ADP
ecj-13710	4	13	diabetes	diabetes	NOUN
ecj-13710	4	14	mellitus	mellitus	NOUN
ecj-13710	4	15	and	and	CCONJ
ecj-13710	4	16	raas	raas	NOUN
ecj-13710	4	17	-	-	PUNCT
ecj-13710	4	18	inhibiting	inhibit	VERB
ecj-13710	4	19	medications	medication	NOUN
ecj-13710	4	20	,	,	PUNCT
ecj-13710	4	21	is	be	AUX
ecj-13710	4	22	a	a	DET
ecj-13710	4	23	significant	significant	ADJ
ecj-13710	4	24	consequence	consequence	NOUN
ecj-13710	4	25	.	.	PUNCT
ecj-13710	5	1	we	we	PRON
ecj-13710	5	2	report	report	VERB
ecj-13710	5	3	a	a	DET
ecj-13710	5	4	56	56	NUM
ecj-13710	5	5	-	-	PUNCT
ecj-13710	5	6	year	year	NOUN
ecj-13710	5	7	-	-	PUNCT
ecj-13710	5	8	old	old	ADJ
ecj-13710	5	9	male	male	NOUN
ecj-13710	5	10	with	with	ADP
ecj-13710	5	11	diabetes	diabetes	NOUN
ecj-13710	5	12	,	,	PUNCT
ecj-13710	5	13	hypertension	hypertension	NOUN
ecj-13710	5	14	,	,	PUNCT
ecj-13710	5	15	and	and	CCONJ
ecj-13710	5	16	coronary	coronary	ADJ
ecj-13710	5	17	artery	artery	NOUN
ecj-13710	5	18	disease	disease	NOUN
ecj-13710	5	19	who	who	PRON
ecj-13710	5	20	developed	develop	VERB
ecj-13710	5	21	type	type	NOUN
ecj-13710	5	22	4	4	NUM
ecj-13710	5	23	rta	rta	NOUN
ecj-13710	5	24	after	after	ADP
ecj-13710	5	25	starting	start	VERB
ecj-13710	5	26	telmisartan	telmisartan	PROPN
ecj-13710	5	27	post	post	ADJ
ecj-13710	5	28	-	-	ADJ
ecj-13710	5	29	hip	hip	ADJ
ecj-13710	5	30	replacement	replacement	NOUN
ecj-13710	5	31	.	.	PUNCT
ecj-13710	6	1	his	his	PRON
ecj-13710	6	2	course	course	NOUN
ecj-13710	6	3	was	be	AUX
ecj-13710	6	4	complicated	complicate	VERB
ecj-13710	6	5	by	by	ADP
ecj-13710	6	6	pneumonia	pneumonia	NOUN
ecj-13710	6	7	and	and	CCONJ
ecj-13710	6	8	worsening	worsen	VERB
ecj-13710	6	9	hyperkalemia	hyperkalemia	NOUN
ecj-13710	6	10	,	,	PUNCT
ecj-13710	6	11	with	with	ADP
ecj-13710	6	12	arterial	arterial	ADJ
ecj-13710	6	13	blood	blood	NOUN
ecj-13710	6	14	gas	gas	NOUN
ecj-13710	6	15	showing	show	VERB
ecj-13710	6	16	normal	normal	ADJ
ecj-13710	6	17	anion	anion	NOUN
ecj-13710	6	18	gap	gap	NOUN
ecj-13710	6	19	metabolic	metabolic	NOUN
ecj-13710	6	20	acidosis	acidosis	NOUN
ecj-13710	6	21	(	(	PUNCT
ecj-13710	6	22	nagma	nagma	NOUN
ecj-13710	6	23	)	)	PUNCT
ecj-13710	6	24	and	and	CCONJ
ecj-13710	6	25	a	a	DET
ecj-13710	6	26	positive	positive	ADJ
ecj-13710	6	27	urinary	urinary	ADJ
ecj-13710	6	28	anion	anion	NOUN
ecj-13710	6	29	gap	gap	NOUN
ecj-13710	6	30	.	.	PUNCT
ecj-13710	7	1	discontinuing	discontinue	VERB
ecj-13710	7	2	telmisartan	telmisartan	NOUN
ecj-13710	7	3	and	and	CCONJ
ecj-13710	7	4	initiating	initiate	VERB
ecj-13710	7	5	hydrocortisone	hydrocortisone	NOUN
ecj-13710	7	6	led	lead	VERB
ecj-13710	7	7	to	to	ADP
ecj-13710	7	8	significant	significant	ADJ
ecj-13710	7	9	renal	renal	ADJ
ecj-13710	7	10	function	function	NOUN
ecj-13710	7	11	improvement	improvement	NOUN
ecj-13710	7	12	and	and	CCONJ
ecj-13710	7	13	potassium	potassium	NOUN
ecj-13710	7	14	normalization	normalization	NOUN
ecj-13710	7	15	.	.	PUNCT
ecj-13710	8	1	this	this	DET
ecj-13710	8	2	case	case	NOUN
ecj-13710	8	3	highlights	highlight	VERB
ecj-13710	8	4	the	the	DET
ecj-13710	8	5	importance	importance	NOUN
ecj-13710	8	6	of	of	ADP
ecj-13710	8	7	caution	caution	NOUN
ecj-13710	8	8	when	when	SCONJ
ecj-13710	8	9	using	use	VERB
ecj-13710	8	10	raas	raas	NOUN
ecj-13710	8	11	inhibitors	inhibitor	NOUN
ecj-13710	8	12	in	in	ADP
ecj-13710	8	13	high	high	ADJ
ecj-13710	8	14	-	-	PUNCT
ecj-13710	8	15	risk	risk	NOUN
ecj-13710	8	16	patients	patient	NOUN
ecj-13710	8	17	and	and	CCONJ
ecj-13710	8	18	supports	support	VERB
ecj-13710	8	19	hydrocortisone	hydrocortisone	NOUN
ecj-13710	8	20	as	as	ADP
ecj-13710	8	21	a	a	DET
ecj-13710	8	22	viable	viable	ADJ
ecj-13710	8	23	alternative	alternative	NOUN
ecj-13710	8	24	when	when	SCONJ
ecj-13710	8	25	fludrocortisone	fludrocortisone	NOUN
ecj-13710	8	26	is	be	AUX
ecj-13710	8	27	unavailable	unavailable	ADJ
ecj-13710	8	28	.	.	PUNCT
ecj-13710	9	1	case	case	NOUN
ecj-13710	9	2	report	report	VERB
ecj-13710	9	3	a	a	DET
ecj-13710	9	4	56	56	NUM
ecj-13710	9	5	-	-	PUNCT
ecj-13710	9	6	year	year	NOUN
ecj-13710	9	7	-	-	PUNCT
ecj-13710	9	8	old	old	ADJ
ecj-13710	9	9	male	male	ADJ
ecj-13710	9	10	patient	patient	NOUN
ecj-13710	9	11	was	be	AUX
ecj-13710	9	12	referred	refer	VERB
ecj-13710	9	13	to	to	ADP
ecj-13710	9	14	our	our	PRON
ecj-13710	9	15	department	department	NOUN
ecj-13710	9	16	following	follow	VERB
ecj-13710	9	17	a	a	DET
ecj-13710	9	18	complicated	complicated	ADJ
ecj-13710	9	19	postoperative	postoperative	ADJ
ecj-13710	9	20	course	course	NOUN
ecj-13710	9	21	.	.	PUNCT
ecj-13710	10	1	his	his	PRON
ecj-13710	10	2	medical	medical	ADJ
ecj-13710	10	3	history	history	NOUN
ecj-13710	10	4	was	be	AUX
ecj-13710	10	5	significant	significant	ADJ
ecj-13710	10	6	for	for	ADP
ecj-13710	10	7	dm2	dm2	PROPN
ecj-13710	10	8	,	,	PUNCT
ecj-13710	10	9	hypercholesterolemia	hypercholesterolemia	NOUN
ecj-13710	10	10	,	,	PUNCT
ecj-13710	10	11	hypertension	hypertension	NOUN
ecj-13710	10	12	,	,	PUNCT
ecj-13710	10	13	and	and	CCONJ
ecj-13710	10	14	chronic	chronic	ADJ
ecj-13710	10	15	stable	stable	ADJ
ecj-13710	10	16	coronary	coronary	ADJ
ecj-13710	10	17	artery	artery	NOUN
ecj-13710	10	18	disease	disease	NOUN
ecj-13710	10	19	.	.	PUNCT
ecj-13710	11	1	his	his	PRON
ecj-13710	11	2	home	home	NOUN
ecj-13710	11	3	medications	medication	NOUN
ecj-13710	11	4	included	include	VERB
ecj-13710	11	5	amlodipine	amlodipine	NOUN
ecj-13710	11	6	and	and	CCONJ
ecj-13710	11	7	insulin	insulin	NOUN
ecj-13710	11	8	;	;	PUNCT
ecj-13710	11	9	however	however	ADV
ecj-13710	11	10	,	,	PUNCT
ecj-13710	11	11	he	he	PRON
ecj-13710	11	12	reported	report	VERB
ecj-13710	11	13	poor	poor	ADJ
ecj-13710	11	14	adherence	adherence	NOUN
ecj-13710	11	15	to	to	ADP
ecj-13710	11	16	his	his	PRON
ecj-13710	11	17	prescribed	prescribed	ADJ
ecj-13710	11	18	regimen	regiman	NOUN
ecj-13710	11	19	.	.	PUNCT
ecj-13710	12	1	the	the	DET
ecj-13710	12	2	patient	patient	NOUN
ecj-13710	12	3	had	have	AUX
ecj-13710	12	4	undergone	undergo	VERB
ecj-13710	12	5	right	right	ADV
ecj-13710	12	6	hip	hip	NOUN
ecj-13710	12	7	replacement	replacement	NOUN
ecj-13710	12	8	surgery	surgery	NOUN
ecj-13710	12	9	at	at	ADP
ecj-13710	12	10	the	the	DET
ecj-13710	12	11	referring	refer	VERB
ecj-13710	12	12	hospital	hospital	NOUN
ecj-13710	12	13	,	,	PUNCT
ecj-13710	12	14	where	where	SCONJ
ecj-13710	12	15	the	the	DET
ecj-13710	12	16	intraoperative	intraoperative	ADJ
ecj-13710	12	17	course	course	NOUN
ecj-13710	12	18	was	be	AUX
ecj-13710	12	19	uneventful	uneventful	ADJ
ecj-13710	12	20	.	.	PUNCT
ecj-13710	13	1	however	however	ADV
ecj-13710	13	2	,	,	PUNCT
ecj-13710	13	3	by	by	ADP
ecj-13710	13	4	postoperative	postoperative	ADJ
ecj-13710	13	5	day	day	NOUN
ecj-13710	13	6	7	7	NUM
ecj-13710	13	7	,	,	PUNCT
ecj-13710	13	8	his	his	PRON
ecj-13710	13	9	recovery	recovery	NOUN
ecj-13710	13	10	was	be	AUX
ecj-13710	13	11	complicated	complicate	VERB
ecj-13710	13	12	by	by	ADP
ecj-13710	13	13	pneumonia	pneumonia	NOUN
ecj-13710	13	14	associated	associate	VERB
ecj-13710	13	15	with	with	ADP
ecj-13710	13	16	poorly	poorly	ADV
ecj-13710	13	17	controlled	control	VERB
ecj-13710	13	18	blood	blood	NOUN
ecj-13710	13	19	glucose	glucose	NOUN
ecj-13710	13	20	levels	level	NOUN
ecj-13710	13	21	and	and	CCONJ
ecj-13710	13	22	blood	blood	NOUN
ecj-13710	13	23	pressure	pressure	NOUN
ecj-13710	13	24	,	,	PUNCT
ecj-13710	13	25	necessitating	necessitate	VERB
ecj-13710	13	26	his	his	PRON
ecj-13710	13	27	transfer	transfer	NOUN
ecj-13710	13	28	to	to	ADP
ecj-13710	13	29	our	our	PRON
ecj-13710	13	30	hospital	hospital	NOUN
ecj-13710	13	31	for	for	ADP
ecj-13710	13	32	further	further	ADJ
ecj-13710	13	33	management	management	NOUN
ecj-13710	13	34	.	.	PUNCT
ecj-13710	14	1	upon	upon	SCONJ
ecj-13710	14	2	admission	admission	NOUN
ecj-13710	14	3	,	,	PUNCT
ecj-13710	14	4	he	he	PRON
ecj-13710	14	5	presented	present	VERB
ecj-13710	14	6	with	with	ADP
ecj-13710	14	7	mild	mild	ADJ
ecj-13710	14	8	dyspnea	dyspnea	NOUN
ecj-13710	14	9	but	but	CCONJ
ecj-13710	14	10	remained	remain	VERB
ecj-13710	14	11	hemodynamically	hemodynamically	ADV
ecj-13710	14	12	stable	stable	ADJ
ecj-13710	14	13	.	.	PUNCT
ecj-13710	15	1	initial	initial	ADJ
ecj-13710	15	2	laboratory	laboratory	NOUN
ecj-13710	15	3	investigations	investigation	NOUN
ecj-13710	15	4	revealed	reveal	VERB
ecj-13710	15	5	mild	mild	ADJ
ecj-13710	15	6	anemia	anemia	NOUN
ecj-13710	15	7	,	,	PUNCT
ecj-13710	15	8	leukocytosis	leukocytosis	NOUN
ecj-13710	15	9	,	,	PUNCT
ecj-13710	15	10	and	and	CCONJ
ecj-13710	15	11	significantly	significantly	ADV
ecj-13710	15	12	elevated	elevated	ADJ
ecj-13710	15	13	inflammatory	inflammatory	ADJ
ecj-13710	15	14	markers	marker	NOUN
ecj-13710	15	15	,	,	PUNCT
ecj-13710	15	16	while	while	SCONJ
ecj-13710	15	17	other	other	ADJ
ecj-13710	15	18	parameters	parameter	NOUN
ecj-13710	15	19	were	be	AUX
ecj-13710	15	20	unremarkable	unremarkable	ADJ
ecj-13710	15	21	.	.	PUNCT
ecj-13710	16	1	the	the	DET
ecj-13710	16	2	patient	patient	NOUN
ecj-13710	16	3	had	have	AUX
ecj-13710	16	4	been	be	AUX
ecj-13710	16	5	receiving	receive	VERB
ecj-13710	16	6	subcutaneous	subcutaneous	ADJ
ecj-13710	16	7	low	low	ADJ
ecj-13710	16	8	molecular	molecular	ADJ
ecj-13710	16	9	weight	weight	NOUN
ecj-13710	16	10	heparin	heparin	NOUN
ecj-13710	16	11	(	(	PUNCT
ecj-13710	16	12	lmwh	lmwh	PROPN
ecj-13710	16	13	)	)	PUNCT
ecj-13710	16	14	60	60	NUM
ecj-13710	16	15	mg	mg	NUM
ecj-13710	16	16	/	/	SYM
ecj-13710	16	17	day	day	NOUN
ecj-13710	16	18	since	since	SCONJ
ecj-13710	16	19	the	the	DET
ecj-13710	16	20	first	first	ADJ
ecj-13710	16	21	postoperative	postoperative	ADJ
ecj-13710	16	22	day	day	NOUN
ecj-13710	16	23	for	for	ADP
ecj-13710	16	24	deep	deep	ADJ
ecj-13710	16	25	vein	vein	ADJ
ecj-13710	16	26	thrombosis	thrombosis	NOUN
ecj-13710	16	27	(	(	PUNCT
ecj-13710	16	28	dvt	dvt	PROPN
ecj-13710	16	29	)	)	PUNCT
ecj-13710	16	30	prophylaxis	prophylaxis	NOUN
ecj-13710	16	31	and	and	CCONJ
ecj-13710	16	32	was	be	AUX
ecj-13710	16	33	initiated	initiate	VERB
ecj-13710	16	34	on	on	ADP
ecj-13710	16	35	antibiotics	antibiotic	NOUN
ecj-13710	16	36	for	for	ADP
ecj-13710	16	37	his	his	PRON
ecj-13710	16	38	pneumonia	pneumonia	NOUN
ecj-13710	16	39	.	.	PUNCT
ecj-13710	17	1	notably	notably	ADV
ecj-13710	17	2	,	,	PUNCT
ecj-13710	17	3	he	he	PRON
ecj-13710	17	4	had	have	VERB
ecj-13710	17	5	no	no	DET
ecj-13710	17	6	prior	prior	ADJ
ecj-13710	17	7	history	history	NOUN
ecj-13710	17	8	of	of	ADP
ecj-13710	17	9	treatment	treatment	NOUN
ecj-13710	17	10	with	with	ADP
ecj-13710	17	11	angiotensin	angiotensin	NOUN
ecj-13710	17	12	receptor	receptor	NOUN
ecj-13710	17	13	blockers	blocker	NOUN
ecj-13710	17	14	(	(	PUNCT
ecj-13710	17	15	arbs	arb	NOUN
ecj-13710	17	16	)	)	PUNCT
ecj-13710	17	17	,	,	PUNCT
ecj-13710	17	18	angiotensin	angiotensin	NOUN
ecj-13710	17	19	-	-	PUNCT
ecj-13710	17	20	converting	convert	VERB
ecj-13710	17	21	enzyme	enzyme	NOUN
ecj-13710	17	22	inhibitors	inhibitor	NOUN
ecj-13710	17	23	(	(	PUNCT
ecj-13710	17	24	ace	ace	VERB
ecj-13710	17	25	inhibitors	inhibitor	NOUN
ecj-13710	17	26	)	)	PUNCT
ecj-13710	17	27	,	,	PUNCT
ecj-13710	17	28	or	or	CCONJ
ecj-13710	17	29	nonsteroidal	nonsteroidal	NOUN
ecj-13710	17	30	antiinflammatory	antiinflammatory	NOUN
ecj-13710	17	31	drugs	drug	NOUN
ecj-13710	17	32	(	(	PUNCT
ecj-13710	17	33	nsaids	nsaid	NOUN
ecj-13710	17	34	)	)	PUNCT
ecj-13710	17	35	.	.	PUNCT
ecj-13710	18	1	given	give	VERB
ecj-13710	18	2	his	his	PRON
ecj-13710	18	3	clinical	clinical	ADJ
ecj-13710	18	4	status	status	NOUN
ecj-13710	18	5	,	,	PUNCT
ecj-13710	18	6	telmisartan	telmisartan	NOUN
ecj-13710	18	7	40	40	NUM
ecj-13710	18	8	mg	mg	ADP
ecj-13710	18	9	once	once	ADV
ecj-13710	18	10	daily	daily	ADV
ecj-13710	18	11	was	be	AUX
ecj-13710	18	12	introduced	introduce	VERB
ecj-13710	18	13	on	on	ADP
ecj-13710	18	14	postoperative	postoperative	ADJ
ecj-13710	18	15	day	day	NOUN
ecj-13710	18	16	8	8	NUM
ecj-13710	18	17	to	to	PART
ecj-13710	18	18	manage	manage	VERB
ecj-13710	18	19	his	his	PRON
ecj-13710	18	20	hypertension	hypertension	NOUN
ecj-13710	18	21	(	(	PUNCT
ecj-13710	18	22	supplementary	supplementary	ADJ
ecj-13710	18	23	materials	material	NOUN
ecj-13710	18	24	,	,	PUNCT
ecj-13710	18	25	table	table	NOUN
ecj-13710	18	26	1	1	NUM
ecj-13710	18	27	)	)	PUNCT
ecj-13710	18	28	.	.	PUNCT
ecj-13710	19	1	lmwh	lmwh	PROPN
ecj-13710	19	2	was	be	AUX
ecj-13710	19	3	discontinued	discontinue	VERB
ecj-13710	19	4	on	on	ADP
ecj-13710	19	5	postoperative	postoperative	ADJ
ecj-13710	19	6	day	day	NOUN
ecj-13710	19	7	10	10	NUM
ecj-13710	19	8	and	and	CCONJ
ecj-13710	19	9	replaced	replace	VERB
ecj-13710	19	10	with	with	ADP
ecj-13710	19	11	aspirin	aspirin	NOUN
ecj-13710	19	12	.	.	PUNCT
ecj-13710	20	1	the	the	DET
ecj-13710	20	2	patient	patient	NOUN
ecj-13710	20	3	remained	remain	VERB
ecj-13710	20	4	clinically	clinically	ADV
ecj-13710	20	5	stable	stable	ADJ
ecj-13710	20	6	throughout	throughout	ADP
ecj-13710	20	7	his	his	PRON
ecj-13710	20	8	hospitalization	hospitalization	NOUN
ecj-13710	20	9	.	.	PUNCT
ecj-13710	21	1	however	however	ADV
ecj-13710	21	2	,	,	PUNCT
ecj-13710	21	3	by	by	ADP
ecj-13710	21	4	postoperative	postoperative	ADJ
ecj-13710	21	5	day	day	NOUN
ecj-13710	21	6	10	10	NUM
ecj-13710	21	7	,	,	PUNCT
ecj-13710	21	8	his	his	PRON
ecj-13710	21	9	leukocyte	leukocyte	NOUN
ecj-13710	21	10	count	count	NOUN
ecj-13710	21	11	exhibited	exhibit	VERB
ecj-13710	21	12	a	a	DET
ecj-13710	21	13	gradual	gradual	ADJ
ecj-13710	21	14	increase	increase	NOUN
ecj-13710	21	15	,	,	PUNCT
ecj-13710	21	16	peaking	peak	VERB
ecj-13710	21	17	at	at	ADP
ecj-13710	21	18	24.64	24.64	NUM
ecj-13710	21	19	g	g	NOUN
ecj-13710	21	20	/	/	SYM
ecj-13710	21	21	l	l	NOUN
ecj-13710	21	22	on	on	ADP
ecj-13710	21	23	postoperative	postoperative	ADJ
ecj-13710	21	24	day	day	NOUN
ecj-13710	21	25	14	14	NUM
ecj-13710	21	26	(	(	PUNCT
ecj-13710	21	27	table	table	NOUN
ecj-13710	21	28	1	1	NUM
ecj-13710	21	29	)	)	PUNCT
ecj-13710	21	30	.	.	PUNCT
ecj-13710	22	1	concurrently	concurrently	ADV
ecj-13710	22	2	,	,	PUNCT
ecj-13710	22	3	his	his	PRON
ecj-13710	22	4	platelet	platelet	NOUN
ecj-13710	22	5	count	count	NOUN
ecj-13710	22	6	increased	increase	VERB
ecj-13710	22	7	from	from	ADP
ecj-13710	22	8	baseline	baseline	NOUN
ecj-13710	22	9	,	,	PUNCT
ecj-13710	22	10	fluctuating	fluctuate	VERB
ecj-13710	22	11	between	between	ADP
ecj-13710	22	12	511	511	NUM
ecj-13710	22	13	and	and	CCONJ
ecj-13710	22	14	636	636	NUM
ecj-13710	22	15	g	g	NOUN
ecj-13710	22	16	/	/	SYM
ecj-13710	22	17	l	l	NOUN
ecj-13710	22	18	,	,	PUNCT
ecj-13710	22	19	likely	likely	ADV
ecj-13710	22	20	reflecting	reflect	VERB
ecj-13710	22	21	reactive	reactive	ADJ
ecj-13710	22	22	leukocytosis	leukocytosis	NOUN
ecj-13710	22	23	and	and	CCONJ
ecj-13710	22	24	thrombocytosis	thrombocytosis	VERB
ecj-13710	22	25	secondary	secondary	ADJ
ecj-13710	22	26	to	to	ADP
ecj-13710	22	27	anemia	anemia	NOUN
ecj-13710	22	28	.	.	PUNCT
ecj-13710	23	1	on	on	ADP
ecj-13710	23	2	postoperative	postoperative	ADJ
ecj-13710	23	3	day	day	NOUN
ecj-13710	23	4	12	12	NUM
ecj-13710	23	5	,	,	PUNCT
ecj-13710	23	6	a	a	DET
ecj-13710	23	7	rise	rise	NOUN
ecj-13710	23	8	in	in	ADP
ecj-13710	23	9	serum	serum	NOUN
ecj-13710	23	10	potassium	potassium	NOUN
ecj-13710	23	11	levels	level	NOUN
ecj-13710	23	12	to	to	ADP
ecj-13710	23	13	5.1	5.1	NUM
ecj-13710	23	14	mmol	mmol	NOUN
ecj-13710	23	15	/	/	SYM
ecj-13710	23	16	l	l	NOUN
ecj-13710	23	17	was	be	AUX
ecj-13710	23	18	noted	note	VERB
ecj-13710	23	19	and	and	CCONJ
ecj-13710	23	20	was	be	AUX
ecj-13710	23	21	managed	manage	VERB
ecj-13710	23	22	with	with	ADP
ecj-13710	23	23	intravenous	intravenous	ADJ
ecj-13710	23	24	furosemide	furosemide	NOUN
ecj-13710	23	25	(	(	PUNCT
ecj-13710	23	26	20	20	NUM
ecj-13710	23	27	mg	mg	NUM
ecj-13710	23	28	/	/	SYM
ecj-13710	23	29	day	day	NOUN
ecj-13710	23	30	)	)	PUNCT
ecj-13710	23	31	.	.	PUNCT
ecj-13710	24	1	however	however	ADV
ecj-13710	24	2	,	,	PUNCT
ecj-13710	24	3	by	by	ADP
ecj-13710	24	4	postoperative	postoperative	ADJ
ecj-13710	24	5	day	day	NOUN
ecj-13710	24	6	14	14	NUM
ecj-13710	24	7	,	,	PUNCT
ecj-13710	24	8	a	a	DET
ecj-13710	24	9	marked	mark	VERB
ecj-13710	24	10	increase	increase	NOUN
ecj-13710	24	11	in	in	ADP
ecj-13710	24	12	serum	serum	NOUN
ecj-13710	24	13	creatinine	creatinine	NOUN
ecj-13710	24	14	levels	level	NOUN
ecj-13710	24	15	from	from	ADP
ecj-13710	24	16	a	a	DET
ecj-13710	24	17	baseline	baseline	NOUN
ecj-13710	24	18	of	of	ADP
ecj-13710	24	19	correspondence	correspondence	NOUN
ecj-13710	24	20	:	:	PUNCT
ecj-13710	24	21	thang	thang	PROPN
ecj-13710	24	22	nguyen	nguyen	PROPN
ecj-13710	24	23	ngoc	ngoc	PROPN
ecj-13710	24	24	,	,	PUNCT
ecj-13710	24	25	intensive	intensive	ADJ
ecj-13710	24	26	care	care	NOUN
ecj-13710	24	27	and	and	CCONJ
ecj-13710	24	28	emergency	emergency	NOUN
ecj-13710	24	29	center	center	NOUN
ecj-13710	24	30	,	,	PUNCT
ecj-13710	24	31	phenikaa	phenikaa	PROPN
ecj-13710	24	32	university	university	NOUN
ecj-13710	24	33	hospital	hospital	NOUN
ecj-13710	24	34	,	,	PUNCT
ecj-13710	24	35	kieu	kieu	PROPN
ecj-13710	24	36	mai	mai	PROPN
ecj-13710	24	37	street	street	PROPN
ecj-13710	24	38	,	,	PUNCT
ecj-13710	24	39	ha	ha	INTJ
ecj-13710	24	40	noi	noi	PROPN
ecj-13710	24	41	,	,	PUNCT
ecj-13710	24	42	vietnam	vietnam	PROPN
ecj-13710	24	43	.	.	PUNCT
ecj-13710	24	44	tel	tel	PROPN
ecj-13710	24	45	.	.	PUNCT
ecj-13710	24	46	:	:	PUNCT
ecj-13710	24	47	+84397913937	+84397913937	NUM
ecj-13710	24	48	e	e	X
ecj-13710	24	49	-	-	NOUN
ecj-13710	24	50	mail	mail	NOUN
ecj-13710	24	51	:	:	PUNCT
ecj-13710	24	52	anh3tue@gmail.com	anh3tue@gmail.com	PROPN
ecj-13710	24	53	key	key	ADJ
ecj-13710	24	54	words	word	NOUN
ecj-13710	24	55	:	:	PUNCT
ecj-13710	24	56	renal	renal	ADJ
ecj-13710	24	57	tubular	tubular	ADJ
ecj-13710	24	58	acidosis	acidosis	NOUN
ecj-13710	24	59	;	;	PUNCT
ecj-13710	24	60	telmisartan	telmisartan	NOUN
ecj-13710	24	61	;	;	PUNCT
ecj-13710	24	62	diabetes	diabetes	NOUN
ecj-13710	24	63	melitus	melitus	NOUN
ecj-13710	24	64	;	;	PUNCT
ecj-13710	24	65	metabolic	metabolic	NOUN
ecj-13710	24	66	acidosis	acidosis	NOUN
ecj-13710	24	67	;	;	PUNCT
ecj-13710	24	68	case	case	NOUN
ecj-13710	24	69	report	report	NOUN
ecj-13710	24	70	.	.	PUNCT
ecj-13710	25	1	ethics	ethic	NOUN
ecj-13710	25	2	approval	approval	NOUN
ecj-13710	25	3	and	and	CCONJ
ecj-13710	25	4	consent	consent	NOUN
ecj-13710	25	5	to	to	PART
ecj-13710	25	6	participate	participate	VERB
ecj-13710	25	7	:	:	PUNCT
ecj-13710	25	8	no	no	DET
ecj-13710	25	9	ethical	ethical	ADJ
ecj-13710	25	10	committee	committee	NOUN
ecj-13710	25	11	approval	approval	NOUN
ecj-13710	25	12	was	be	AUX
ecj-13710	25	13	required	require	VERB
ecj-13710	25	14	for	for	ADP
ecj-13710	25	15	this	this	DET
ecj-13710	25	16	case	case	NOUN
ecj-13710	25	17	report	report	NOUN
ecj-13710	25	18	by	by	ADP
ecj-13710	25	19	the	the	DET
ecj-13710	25	20	department	department	NOUN
ecj-13710	25	21	,	,	PUNCT
ecj-13710	25	22	because	because	SCONJ
ecj-13710	25	23	this	this	DET
ecj-13710	25	24	article	article	NOUN
ecj-13710	25	25	does	do	AUX
ecj-13710	25	26	not	not	PART
ecj-13710	25	27	contain	contain	VERB
ecj-13710	25	28	any	any	DET
ecj-13710	25	29	studies	study	NOUN
ecj-13710	25	30	with	with	ADP
ecj-13710	25	31	human	human	ADJ
ecj-13710	25	32	participants	participant	NOUN
ecj-13710	25	33	or	or	CCONJ
ecj-13710	25	34	animals	animal	NOUN
ecj-13710	25	35	.	.	PUNCT
ecj-13710	26	1	informed	inform	VERB
ecj-13710	26	2	consent	consent	NOUN
ecj-13710	26	3	was	be	AUX
ecj-13710	26	4	obtained	obtain	VERB
ecj-13710	26	5	from	from	ADP
ecj-13710	26	6	the	the	DET
ecj-13710	26	7	patient	patient	NOUN
ecj-13710	26	8	included	include	VERB
ecj-13710	26	9	in	in	ADP
ecj-13710	26	10	this	this	DET
ecj-13710	26	11	study	study	NOUN
ecj-13710	26	12	.	.	PUNCT
ecj-13710	27	1	written	write	VERB
ecj-13710	27	2	informed	informed	ADJ
ecj-13710	27	3	consent	consent	NOUN
ecj-13710	27	4	for	for	ADP
ecj-13710	27	5	publication	publication	NOUN
ecj-13710	27	6	of	of	ADP
ecj-13710	27	7	this	this	DET
ecj-13710	27	8	case	case	NOUN
ecj-13710	27	9	report	report	NOUN
ecj-13710	27	10	and	and	CCONJ
ecj-13710	27	11	accompanying	accompany	VERB
ecj-13710	27	12	table	table	NOUN
ecj-13710	27	13	was	be	AUX
ecj-13710	27	14	obtained	obtain	VERB
ecj-13710	27	15	from	from	ADP
ecj-13710	27	16	the	the	DET
ecj-13710	27	17	patient	patient	NOUN
ecj-13710	27	18	.	.	PUNCT
ecj-13710	28	1	availability	availability	NOUN
ecj-13710	28	2	of	of	ADP
ecj-13710	28	3	data	datum	NOUN
ecj-13710	28	4	and	and	CCONJ
ecj-13710	28	5	material	material	NOUN
ecj-13710	28	6	:	:	PUNCT
ecj-13710	28	7	all	all	DET
ecj-13710	28	8	data	datum	NOUN
ecj-13710	28	9	generated	generate	VERB
ecj-13710	28	10	or	or	CCONJ
ecj-13710	28	11	analyzed	analyze	VERB
ecj-13710	28	12	during	during	ADP
ecj-13710	28	13	this	this	DET
ecj-13710	28	14	study	study	NOUN
ecj-13710	28	15	are	be	AUX
ecj-13710	28	16	available	available	ADJ
ecj-13710	28	17	upon	upon	SCONJ
ecj-13710	28	18	request	request	NOUN
ecj-13710	28	19	.	.	PUNCT
ecj-13710	29	1	conflict	conflict	NOUN
ecj-13710	29	2	of	of	ADP
ecj-13710	29	3	interest	interest	NOUN
ecj-13710	29	4	:	:	PUNCT
ecj-13710	29	5	the	the	DET
ecj-13710	29	6	authors	author	NOUN
ecj-13710	29	7	have	have	VERB
ecj-13710	29	8	no	no	DET
ecj-13710	29	9	conflicts	conflict	NOUN
ecj-13710	29	10	of	of	ADP
ecj-13710	29	11	interest	interest	NOUN
ecj-13710	29	12	to	to	PART
ecj-13710	29	13	declare	declare	VERB
ecj-13710	29	14	contributions	contribution	NOUN
ecj-13710	29	15	:	:	PUNCT
ecj-13710	29	16	tnn	tnn	PROPN
ecj-13710	29	17	,	,	PUNCT
ecj-13710	29	18	study	study	NOUN
ecj-13710	29	19	concept	concept	NOUN
ecj-13710	29	20	,	,	PUNCT
ecj-13710	29	21	design	design	NOUN
ecj-13710	29	22	,	,	PUNCT
ecj-13710	29	23	collection	collection	NOUN
ecj-13710	29	24	and	and	CCONJ
ecj-13710	29	25	assembly	assembly	NOUN
ecj-13710	29	26	of	of	ADP
ecj-13710	29	27	data	data	PROPN
ecj-13710	29	28	,	,	PUNCT
ecj-13710	29	29	manuscript	manuscript	VERB
ecj-13710	29	30	original	original	ADJ
ecj-13710	29	31	drafting	drafting	NOUN
ecj-13710	29	32	;	;	PUNCT
ecj-13710	29	33	vnt	vnt	PROPN
ecj-13710	29	34	,	,	PUNCT
ecj-13710	29	35	administrative	administrative	ADJ
ecj-13710	29	36	support	support	NOUN
ecj-13710	29	37	,	,	PUNCT
ecj-13710	29	38	provision	provision	NOUN
ecj-13710	29	39	of	of	ADP
ecj-13710	29	40	patients	patient	NOUN
ecj-13710	29	41	,	,	PUNCT
ecj-13710	29	42	contribution	contribution	NOUN
ecj-13710	29	43	to	to	PART
ecj-13710	29	44	manuscript	manuscript	VERB
ecj-13710	29	45	writing	writing	NOUN
ecj-13710	29	46	and	and	CCONJ
ecj-13710	29	47	editing	editing	NOUN
ecj-13710	29	48	;	;	PUNCT
ecj-13710	29	49	snb	snb	PROPN
ecj-13710	29	50	,	,	PUNCT
ecj-13710	29	51	contribution	contribution	NOUN
ecj-13710	29	52	to	to	PART
ecj-13710	29	53	manuscript	manuscript	VERB
ecj-13710	29	54	writing	writing	NOUN
ecj-13710	29	55	and	and	CCONJ
ecj-13710	29	56	editing	editing	NOUN
ecj-13710	29	57	;	;	PUNCT
ecj-13710	29	58	mnn	mnn	NOUN
ecj-13710	29	59	,	,	PUNCT
ecj-13710	29	60	contribution	contribution	NOUN
ecj-13710	29	61	to	to	PART
ecj-13710	29	62	manuscript	manuscript	VERB
ecj-13710	29	63	writing	writing	NOUN
ecj-13710	29	64	and	and	CCONJ
ecj-13710	29	65	editing	editing	NOUN
ecj-13710	29	66	.	.	PUNCT
ecj-13710	30	1	all	all	DET
ecj-13710	30	2	the	the	DET
ecj-13710	30	3	authors	author	NOUN
ecj-13710	30	4	read	read	VERB
ecj-13710	30	5	and	and	CCONJ
ecj-13710	30	6	approved	approve	VERB
ecj-13710	30	7	the	the	DET
ecj-13710	30	8	final	final	ADJ
ecj-13710	30	9	version	version	NOUN
ecj-13710	30	10	of	of	ADP
ecj-13710	30	11	the	the	DET
ecj-13710	30	12	manuscript	manuscript	NOUN
ecj-13710	30	13	and	and	CCONJ
ecj-13710	30	14	agreed	agree	VERB
ecj-13710	30	15	to	to	PART
ecj-13710	30	16	be	be	AUX
ecj-13710	30	17	accountable	accountable	ADJ
ecj-13710	30	18	for	for	ADP
ecj-13710	30	19	all	all	DET
ecj-13710	30	20	aspects	aspect	NOUN
ecj-13710	30	21	of	of	ADP
ecj-13710	30	22	the	the	DET
ecj-13710	30	23	work	work	NOUN
ecj-13710	30	24	.	.	PUNCT
ecj-13710	31	1	acknowledgments	acknowledgment	NOUN
ecj-13710	31	2	:	:	PUNCT
ecj-13710	32	1	we	we	PRON
ecj-13710	32	2	sincerely	sincerely	ADV
ecj-13710	32	3	thank	thank	VERB
ecj-13710	32	4	the	the	DET
ecj-13710	32	5	patient	patient	NOUN
ecj-13710	32	6	for	for	ADP
ecj-13710	32	7	granting	grant	VERB
ecj-13710	32	8	permission	permission	NOUN
ecj-13710	32	9	to	to	PART
ecj-13710	32	10	publish	publish	VERB
ecj-13710	32	11	this	this	DET
ecj-13710	32	12	case	case	NOUN
ecj-13710	32	13	report	report	NOUN
ecj-13710	32	14	.	.	PUNCT
ecj-13710	33	1	received	receive	VERB
ecj-13710	33	2	:	:	PUNCT
ecj-13710	33	3	6	6	NUM
ecj-13710	33	4	february	february	NOUN
ecj-13710	33	5	2025	2025	NUM
ecj-13710	33	6	.	.	PUNCT
ecj-13710	34	1	accepted	accept	VERB
ecj-13710	34	2	:	:	PUNCT
ecj-13710	34	3	29	29	NUM
ecj-13710	34	4	may	may	PROPN
ecj-13710	34	5	2025	2025	NUM
ecj-13710	34	6	.	.	PUNCT
ecj-13710	35	1	early	early	ADJ
ecj-13710	35	2	view	view	NOUN
ecj-13710	35	3	:	:	PUNCT
ecj-13710	35	4	24	24	NUM
ecj-13710	35	5	june	june	PROPN
ecj-13710	35	6	2025	2025	NUM
ecj-13710	35	7	.	.	PUNCT
ecj-13710	36	1	this	this	DET
ecj-13710	36	2	work	work	NOUN
ecj-13710	36	3	is	be	AUX
ecj-13710	36	4	licensed	license	VERB
ecj-13710	36	5	under	under	ADP
ecj-13710	36	6	a	a	DET
ecj-13710	36	7	creative	creative	ADJ
ecj-13710	36	8	commons	common	NOUN
ecj-13710	36	9	attribution	attribution	NOUN
ecj-13710	36	10	4.0	4.0	NUM
ecj-13710	36	11	license	license	NOUN
ecj-13710	36	12	(	(	PUNCT
ecj-13710	36	13	by	by	ADP
ecj-13710	36	14	-	-	PUNCT
ecj-13710	36	15	nc	nc	PROPN
ecj-13710	36	16	4.0	4.0	NUM
ecj-13710	36	17	)	)	PUNCT
ecj-13710	36	18	.	.	PUNCT
ecj-13710	37	1	©	©	PROPN
ecj-13710	37	2	copyright	copyright	NOUN
ecj-13710	37	3	:	:	PUNCT
ecj-13710	37	4	the	the	DET
ecj-13710	37	5	author(s	author(s	PROPN
ecj-13710	37	6	)	)	PUNCT
ecj-13710	37	7	,	,	PUNCT
ecj-13710	37	8	2025	2025	NUM
ecj-13710	37	9	licensee	licensee	NOUN
ecj-13710	37	10	pagepress	pagepress	NOUN
ecj-13710	37	11	,	,	PUNCT
ecj-13710	37	12	italy	italy	PROPN
ecj-13710	37	13	emergency	emergency	PROPN
ecj-13710	37	14	care	care	PROPN
ecj-13710	37	15	journal	journal	PROPN
ecj-13710	37	16	2025	2025	NUM
ecj-13710	37	17	;	;	PUNCT
ecj-13710	37	18	21:13710	21:13710	NUM
ecj-13710	37	19	doi:10.4081	doi:10.4081	NOUN
ecj-13710	37	20	/	/	SYM
ecj-13710	37	21	ecj.2025.13710	ecj.2025.13710	PROPN
ecj-13710	37	22	publisher	publisher	NOUN
ecj-13710	37	23	's	's	PART
ecj-13710	37	24	note	note	NOUN
ecj-13710	37	25	:	:	PUNCT
ecj-13710	37	26	all	all	DET
ecj-13710	37	27	claims	claim	NOUN
ecj-13710	37	28	expressed	express	VERB
ecj-13710	37	29	in	in	ADP
ecj-13710	37	30	this	this	DET
ecj-13710	37	31	article	article	NOUN
ecj-13710	37	32	are	be	AUX
ecj-13710	37	33	solely	solely	ADV
ecj-13710	37	34	those	those	PRON
ecj-13710	37	35	of	of	ADP
ecj-13710	37	36	the	the	DET
ecj-13710	37	37	authors	author	NOUN
ecj-13710	37	38	and	and	CCONJ
ecj-13710	37	39	do	do	AUX
ecj-13710	37	40	not	not	PART
ecj-13710	37	41	necessarily	necessarily	ADV
ecj-13710	37	42	represent	represent	VERB
ecj-13710	37	43	those	those	PRON
ecj-13710	37	44	of	of	ADP
ecj-13710	37	45	their	their	PRON
ecj-13710	37	46	affiliated	affiliated	ADJ
ecj-13710	37	47	organizations	organization	NOUN
ecj-13710	37	48	,	,	PUNCT
ecj-13710	37	49	or	or	CCONJ
ecj-13710	37	50	those	those	PRON
ecj-13710	37	51	of	of	ADP
ecj-13710	37	52	the	the	DET
ecj-13710	37	53	publisher	publisher	NOUN
ecj-13710	37	54	,	,	PUNCT
ecj-13710	37	55	the	the	DET
ecj-13710	37	56	editors	editor	NOUN
ecj-13710	37	57	and	and	CCONJ
ecj-13710	37	58	the	the	DET
ecj-13710	37	59	reviewers	reviewer	NOUN
ecj-13710	37	60	.	.	PUNCT
ecj-13710	38	1	any	any	DET
ecj-13710	38	2	product	product	NOUN
ecj-13710	38	3	that	that	PRON
ecj-13710	38	4	may	may	AUX
ecj-13710	38	5	be	be	AUX
ecj-13710	38	6	evaluated	evaluate	VERB
ecj-13710	38	7	in	in	ADP
ecj-13710	38	8	this	this	DET
ecj-13710	38	9	article	article	NOUN
ecj-13710	38	10	or	or	CCONJ
ecj-13710	38	11	claim	claim	NOUN
ecj-13710	38	12	that	that	PRON
ecj-13710	38	13	may	may	AUX
ecj-13710	38	14	be	be	AUX
ecj-13710	38	15	made	make	VERB
ecj-13710	38	16	by	by	ADP
ecj-13710	38	17	its	its	PRON
ecj-13710	38	18	manufacturer	manufacturer	NOUN
ecj-13710	38	19	is	be	AUX
ecj-13710	38	20	not	not	PART
ecj-13710	38	21	guaranteed	guarantee	VERB
ecj-13710	38	22	or	or	CCONJ
ecj-13710	38	23	endorsed	endorse	VERB
ecj-13710	38	24	by	by	ADP
ecj-13710	38	25	the	the	DET
ecj-13710	38	26	publisher	publisher	NOUN
ecj-13710	38	27	.	.	PUNCT
ecj-13710	39	1	telmisartan	telmisartan	NOUN
ecj-13710	39	2	-	-	PUNCT
ecj-13710	39	3	induced	induce	VERB
ecj-13710	39	4	type	type	NOUN
ecj-13710	39	5	4	4	NUM
ecj-13710	39	6	renal	renal	ADJ
ecj-13710	39	7	tubular	tubular	ADJ
ecj-13710	39	8	acidosis	acidosis	NOUN
ecj-13710	39	9	:	:	PUNCT
ecj-13710	39	10	a	a	DET
ecj-13710	39	11	case	case	NOUN
ecj-13710	39	12	report	report	VERB
ecj-13710	39	13	thang	thang	PROPN
ecj-13710	39	14	nguyen	nguyen	PROPN
ecj-13710	39	15	ngoc	ngoc	PROPN
ecj-13710	39	16	,	,	PUNCT
ecj-13710	39	17	vy	vy	PROPN
ecj-13710	39	18	nong	nong	PROPN
ecj-13710	39	19	thao	thao	PROPN
ecj-13710	39	20	,	,	PUNCT
ecj-13710	39	21	son	son	NOUN
ecj-13710	39	22	nguyen	nguyen	PROPN
ecj-13710	39	23	ba	ba	PROPN
ecj-13710	39	24	,	,	PUNCT
ecj-13710	39	25	nghia	nghia	PROPN
ecj-13710	39	26	nguyen	nguyen	PROPN
ecj-13710	39	27	minh	minh	PROPN
ecj-13710	39	28	phenikaa	phenikaa	PROPN
ecj-13710	39	29	university	university	PROPN
ecj-13710	39	30	hospital	hospital	NOUN
ecj-13710	39	31	,	,	PUNCT
ecj-13710	39	32	ha	ha	INTJ
ecj-13710	39	33	noi	noi	PROPN
ecj-13710	39	34	,	,	PUNCT
ecj-13710	39	35	vietnam	vietnam	PROPN
ecj-13710	39	36	approximately	approximately	ADV
ecj-13710	39	37	1	1	NUM
ecj-13710	39	38	mg	mg	PROPN
ecj-13710	39	39	/	/	SYM
ecj-13710	39	40	dl	dl	PROPN
ecj-13710	39	41	was	be	AUX
ecj-13710	39	42	observed	observe	VERB
ecj-13710	39	43	,	,	PUNCT
ecj-13710	39	44	alongside	alongside	SCONJ
ecj-13710	39	45	a	a	DET
ecj-13710	39	46	peak	peak	NOUN
ecj-13710	39	47	serum	serum	NOUN
ecj-13710	39	48	potassium	potassium	NOUN
ecj-13710	39	49	level	level	NOUN
ecj-13710	39	50	of	of	ADP
ecj-13710	39	51	5.6	5.6	NUM
ecj-13710	39	52	mmol	mmol	NOUN
ecj-13710	39	53	/	/	SYM
ecj-13710	39	54	l.	l.	PROPN
ecj-13710	39	55	pseudohyperkalemia	pseudohyperkalemia	PROPN
ecj-13710	39	56	secondary	secondary	ADJ
ecj-13710	39	57	to	to	ADP
ecj-13710	39	58	thrombocytosis	thrombocytosis	NOUN
ecj-13710	39	59	was	be	AUX
ecj-13710	39	60	ruled	rule	VERB
ecj-13710	39	61	out	out	ADP
ecj-13710	39	62	by	by	ADP
ecj-13710	39	63	repeated	repeat	VERB
ecj-13710	39	64	serum	serum	NOUN
ecj-13710	39	65	and	and	CCONJ
ecj-13710	39	66	plasma	plasma	NOUN
ecj-13710	39	67	potassium	potassium	NOUN
ecj-13710	39	68	measurements	measurement	NOUN
ecj-13710	39	69	.	.	PUNCT
ecj-13710	40	1	since	since	SCONJ
ecj-13710	40	2	the	the	DET
ecj-13710	40	3	patient	patient	NOUN
ecj-13710	40	4	remained	remain	VERB
ecj-13710	40	5	hemodynamically	hemodynamically	ADV
ecj-13710	40	6	stable	stable	ADJ
ecj-13710	40	7	and	and	CCONJ
ecj-13710	40	8	euvolemic	euvolemic	ADJ
ecj-13710	40	9	throughout	throughout	ADP
ecj-13710	40	10	hospitalization	hospitalization	NOUN
ecj-13710	40	11	,	,	PUNCT
ecj-13710	40	12	prerenal	prerenal	ADJ
ecj-13710	40	13	acute	acute	NOUN
ecj-13710	40	14	kidney	kidney	NOUN
ecj-13710	40	15	injury	injury	NOUN
ecj-13710	40	16	due	due	ADP
ecj-13710	40	17	to	to	ADP
ecj-13710	40	18	hypovolemia	hypovolemia	NOUN
ecj-13710	40	19	was	be	AUX
ecj-13710	40	20	ruled	rule	VERB
ecj-13710	40	21	out	out	ADP
ecj-13710	40	22	.	.	PUNCT
ecj-13710	41	1	to	to	PART
ecj-13710	41	2	further	far	ADV
ecj-13710	41	3	evaluate	evaluate	VERB
ecj-13710	41	4	the	the	DET
ecj-13710	41	5	acute	acute	ADJ
ecj-13710	41	6	decline	decline	NOUN
ecj-13710	41	7	in	in	ADP
ecj-13710	41	8	renal	renal	ADJ
ecj-13710	41	9	function	function	NOUN
ecj-13710	41	10	and	and	CCONJ
ecj-13710	41	11	persistent	persistent	ADJ
ecj-13710	41	12	hyperkalemia	hyperkalemia	NOUN
ecj-13710	41	13	—	—	PUNCT
ecj-13710	41	14	which	which	PRON
ecj-13710	41	15	appeared	appear	VERB
ecj-13710	41	16	disproportionate	disproportionate	ADJ
ecj-13710	41	17	to	to	ADP
ecj-13710	41	18	the	the	DET
ecj-13710	41	19	degree	degree	NOUN
ecj-13710	41	20	of	of	ADP
ecj-13710	41	21	renal	renal	ADJ
ecj-13710	41	22	impairment	impairment	NOUN
ecj-13710	41	23	—	—	PUNCT
ecj-13710	41	24	an	an	DET
ecj-13710	41	25	arterial	arterial	ADJ
ecj-13710	41	26	blood	blood	NOUN
ecj-13710	41	27	gas	gas	NOUN
ecj-13710	41	28	(	(	PUNCT
ecj-13710	41	29	abg	abg	ADJ
ecj-13710	41	30	)	)	PUNCT
ecj-13710	41	31	analysis	analysis	NOUN
ecj-13710	41	32	was	be	AUX
ecj-13710	41	33	performed	perform	VERB
ecj-13710	41	34	,	,	PUNCT
ecj-13710	41	35	revealing	reveal	VERB
ecj-13710	41	36	a	a	DET
ecj-13710	41	37	nagma	nagma	NOUN
ecj-13710	41	38	.	.	PUNCT
ecj-13710	42	1	a	a	DET
ecj-13710	42	2	spot	spot	NOUN
ecj-13710	42	3	urine	urine	NOUN
ecj-13710	42	4	electrolyte	electrolyte	ADJ
ecj-13710	42	5	analysis	analysis	NOUN
ecj-13710	42	6	on	on	ADP
ecj-13710	42	7	postoperative	postoperative	ADJ
ecj-13710	42	8	day	day	NOUN
ecj-13710	42	9	15	15	NUM
ecj-13710	42	10	demonstrated	demonstrate	VERB
ecj-13710	42	11	a	a	DET
ecj-13710	42	12	positive	positive	ADJ
ecj-13710	42	13	urinary	urinary	ADJ
ecj-13710	42	14	anion	anion	NOUN
ecj-13710	42	15	gap	gap	NOUN
ecj-13710	42	16	(	(	PUNCT
ecj-13710	42	17	uag	uag	PROPN
ecj-13710	42	18	)	)	PUNCT
ecj-13710	42	19	of	of	ADP
ecj-13710	42	20	54.7	54.7	NUM
ecj-13710	42	21	.	.	PUNCT
ecj-13710	43	1	urinalysis	urinalysis	NOUN
ecj-13710	43	2	findings	finding	NOUN
ecj-13710	43	3	were	be	AUX
ecj-13710	43	4	unremarkable	unremarkable	ADJ
ecj-13710	43	5	,	,	PUNCT
ecj-13710	43	6	with	with	ADP
ecj-13710	43	7	a	a	DET
ecj-13710	43	8	ph	ph	NOUN
ecj-13710	43	9	of	of	ADP
ecj-13710	43	10	6.5	6.5	NUM
ecj-13710	43	11	and	and	CCONJ
ecj-13710	43	12	no	no	DET
ecj-13710	43	13	evidence	evidence	NOUN
ecj-13710	43	14	of	of	ADP
ecj-13710	43	15	infection	infection	NOUN
ecj-13710	43	16	,	,	PUNCT
ecj-13710	43	17	proteinuria	proteinuria	NOUN
ecj-13710	43	18	,	,	PUNCT
ecj-13710	43	19	or	or	CCONJ
ecj-13710	43	20	ketonuria	ketonuria	PROPN
ecj-13710	43	21	;	;	PUNCT
ecj-13710	43	22	however	however	ADV
ecj-13710	43	23	,	,	PUNCT
ecj-13710	43	24	serial	serial	ADJ
ecj-13710	43	25	urine	urine	NOUN
ecj-13710	43	26	ph	ph	ADJ
ecj-13710	43	27	measurements	measurement	NOUN
ecj-13710	43	28	demonstrated	demonstrate	VERB
ecj-13710	43	29	an	an	DET
ecj-13710	43	30	acidic	acidic	ADJ
ecj-13710	43	31	trend	trend	NOUN
ecj-13710	43	32	.	.	PUNCT
ecj-13710	44	1	given	give	VERB
ecj-13710	44	2	that	that	SCONJ
ecj-13710	44	3	other	other	ADJ
ecj-13710	44	4	non	non	ADJ
ecj-13710	44	5	-	-	ADJ
ecj-13710	44	6	renal	renal	ADJ
ecj-13710	44	7	tubular	tubular	ADJ
ecj-13710	44	8	acidosis	acidosis	NOUN
ecj-13710	44	9	causes	cause	NOUN
ecj-13710	44	10	of	of	ADP
ecj-13710	44	11	nagma	nagma	NOUN
ecj-13710	44	12	were	be	AUX
ecj-13710	44	13	excluded	exclude	VERB
ecj-13710	44	14	,	,	PUNCT
ecj-13710	44	15	these	these	DET
ecj-13710	44	16	findings	finding	NOUN
ecj-13710	44	17	were	be	AUX
ecj-13710	44	18	consistent	consistent	ADJ
ecj-13710	44	19	with	with	ADP
ecj-13710	44	20	type	type	NOUN
ecj-13710	44	21	4	4	NUM
ecj-13710	44	22	rta	rta	NOUN
ecj-13710	44	23	.	.	PUNCT
ecj-13710	45	1	due	due	ADP
ecj-13710	45	2	to	to	ADP
ecj-13710	45	3	the	the	DET
ecj-13710	45	4	acute	acute	NOUN
ecj-13710	45	5	worsening	worsening	NOUN
ecj-13710	45	6	of	of	ADP
ecj-13710	45	7	kidney	kidney	NOUN
ecj-13710	45	8	function	function	NOUN
ecj-13710	45	9	,	,	PUNCT
ecj-13710	45	10	refractory	refractory	NOUN
ecj-13710	45	11	hyperkalemia	hyperkalemia	NOUN
ecj-13710	45	12	,	,	PUNCT
ecj-13710	45	13	and	and	CCONJ
ecj-13710	45	14	suspected	suspect	VERB
ecj-13710	45	15	type	type	NOUN
ecj-13710	45	16	4	4	NUM
ecj-13710	45	17	rta	rta	NOUN
ecj-13710	45	18	,	,	PUNCT
ecj-13710	45	19	telmisartan	telmisartan	PROPN
ecj-13710	45	20	was	be	AUX
ecj-13710	45	21	discontinued	discontinue	VERB
ecj-13710	45	22	on	on	ADP
ecj-13710	45	23	postoperative	postoperative	ADJ
ecj-13710	45	24	day	day	NOUN
ecj-13710	45	25	15	15	NUM
ecj-13710	45	26	,	,	PUNCT
ecj-13710	45	27	and	and	CCONJ
ecj-13710	45	28	intravenous	intravenous	ADJ
ecj-13710	45	29	furosemide	furosemide	NOUN
ecj-13710	45	30	was	be	AUX
ecj-13710	45	31	continued	continue	VERB
ecj-13710	45	32	to	to	PART
ecj-13710	45	33	control	control	VERB
ecj-13710	45	34	hyperkalemia	hyperkalemia	NOUN
ecj-13710	45	35	.	.	PUNCT
ecj-13710	46	1	given	give	VERB
ecj-13710	46	2	the	the	DET
ecj-13710	46	3	unavailability	unavailability	NOUN
ecj-13710	46	4	of	of	ADP
ecj-13710	46	5	fludrocortisone	fludrocortisone	NOUN
ecj-13710	46	6	in	in	ADP
ecj-13710	46	7	our	our	PRON
ecj-13710	46	8	department	department	NOUN
ecj-13710	46	9	,	,	PUNCT
ecj-13710	46	10	hydrocortisone	hydrocortisone	PROPN
ecj-13710	46	11	(	(	PUNCT
ecj-13710	46	12	200	200	NUM
ecj-13710	46	13	mg	mg	NUM
ecj-13710	46	14	/	/	SYM
ecj-13710	46	15	day	day	NOUN
ecj-13710	46	16	)	)	PUNCT
ecj-13710	46	17	was	be	AUX
ecj-13710	46	18	initiated	initiate	VERB
ecj-13710	46	19	as	as	ADP
ecj-13710	46	20	an	an	DET
ecj-13710	46	21	alternative	alternative	NOUN
ecj-13710	46	22	to	to	PART
ecj-13710	46	23	manage	manage	VERB
ecj-13710	46	24	the	the	DET
ecj-13710	46	25	patient	patient	NOUN
ecj-13710	46	26	’s	’s	PART
ecj-13710	46	27	tubular	tubular	ADJ
ecj-13710	46	28	dysfunction	dysfunction	NOUN
ecj-13710	46	29	.	.	PUNCT
ecj-13710	47	1	following	follow	VERB
ecj-13710	47	2	the	the	DET
ecj-13710	47	3	discontinuation	discontinuation	NOUN
ecj-13710	47	4	of	of	ADP
ecj-13710	47	5	telmisartan	telmisartan	NOUN
ecj-13710	47	6	and	and	CCONJ
ecj-13710	47	7	the	the	DET
ecj-13710	47	8	introduction	introduction	NOUN
ecj-13710	47	9	of	of	ADP
ecj-13710	47	10	hydrocortisone	hydrocortisone	PROPN
ecj-13710	47	11	,	,	PUNCT
ecj-13710	47	12	renal	renal	ADJ
ecj-13710	47	13	function	function	NOUN
ecj-13710	47	14	improved	improve	VERB
ecj-13710	47	15	significantly	significantly	ADV
ecj-13710	47	16	.	.	PUNCT
ecj-13710	48	1	by	by	ADP
ecj-13710	48	2	postoperative	postoperative	ADJ
ecj-13710	48	3	day	day	NOUN
ecj-13710	48	4	16	16	NUM
ecj-13710	48	5	,	,	PUNCT
ecj-13710	48	6	serum	serum	NOUN
ecj-13710	48	7	creatinine	creatinine	NOUN
ecj-13710	48	8	levels	level	NOUN
ecj-13710	48	9	had	have	AUX
ecj-13710	48	10	returned	return	VERB
ecj-13710	48	11	to	to	AUX
ecj-13710	48	12	baseline	baseline	VERB
ecj-13710	48	13	(	(	PUNCT
ecj-13710	48	14	1.01	1.01	NUM
ecj-13710	48	15	mg	mg	PROPN
ecj-13710	48	16	/	/	SYM
ecj-13710	48	17	dl	dl	PROPN
ecj-13710	48	18	)	)	PUNCT
ecj-13710	48	19	,	,	PUNCT
ecj-13710	48	20	and	and	CCONJ
ecj-13710	48	21	serum	serum	NOUN
ecj-13710	48	22	potassium	potassium	NOUN
ecj-13710	48	23	had	have	AUX
ecj-13710	48	24	decreased	decrease	VERB
ecj-13710	48	25	to	to	ADP
ecj-13710	48	26	5.0	5.0	NUM
ecj-13710	48	27	mmol	mmol	NOUN
ecj-13710	48	28	/	/	SYM
ecj-13710	48	29	l.	l.	NOUN
ecj-13710	48	30	by	by	ADP
ecj-13710	48	31	postoperative	postoperative	ADJ
ecj-13710	48	32	day	day	NOUN
ecj-13710	48	33	17	17	NUM
ecj-13710	48	34	,	,	PUNCT
ecj-13710	48	35	potassium	potassium	NOUN
ecj-13710	48	36	levels	level	NOUN
ecj-13710	48	37	had	have	AUX
ecj-13710	48	38	further	far	ADV
ecj-13710	48	39	normalized	normalize	VERB
ecj-13710	48	40	to	to	ADP
ecj-13710	48	41	4.1	4.1	NUM
ecj-13710	48	42	mmol	mmol	NOUN
ecj-13710	48	43	/	/	SYM
ecj-13710	48	44	l.	l.	NOUN
ecj-13710	48	45	the	the	DET
ecj-13710	48	46	patient	patient	NOUN
ecj-13710	48	47	’s	’s	PART
ecj-13710	48	48	nagma	nagma	NOUN
ecj-13710	48	49	also	also	ADV
ecj-13710	48	50	improved	improve	VERB
ecj-13710	48	51	,	,	PUNCT
ecj-13710	48	52	with	with	ADP
ecj-13710	48	53	normalization	normalization	NOUN
ecj-13710	48	54	of	of	ADP
ecj-13710	48	55	serum	serum	NOUN
ecj-13710	48	56	hco4⁺	hco4⁺	PROPN
ecj-13710	48	57	and	and	CCONJ
ecj-13710	48	58	a	a	DET
ecj-13710	48	59	mild	mild	ADJ
ecj-13710	48	60	reduction	reduction	NOUN
ecj-13710	48	61	in	in	ADP
ecj-13710	48	62	the	the	DET
ecj-13710	48	63	urine	urine	NOUN
ecj-13710	48	64	anion	anion	NOUN
ecj-13710	48	65	gap	gap	NOUN
ecj-13710	48	66	.	.	PUNCT
ecj-13710	49	1	given	give	VERB
ecj-13710	49	2	the	the	DET
ecj-13710	49	3	patient	patient	NOUN
ecj-13710	49	4	’s	’s	PART
ecj-13710	49	5	clinical	clinical	ADJ
ecj-13710	49	6	improvement	improvement	NOUN
ecj-13710	49	7	,	,	PUNCT
ecj-13710	49	8	they	they	PRON
ecj-13710	49	9	were	be	AUX
ecj-13710	49	10	discharged	discharge	VERB
ecj-13710	49	11	on	on	ADP
ecj-13710	49	12	postoperative	postoperative	ADJ
ecj-13710	49	13	day	day	NOUN
ecj-13710	49	14	17	17	NUM
ecj-13710	49	15	with	with	ADP
ecj-13710	49	16	a	a	DET
ecj-13710	49	17	10	10	NUM
ecj-13710	49	18	-	-	PUNCT
ecj-13710	49	19	day	day	NOUN
ecj-13710	49	20	course	course	NOUN
ecj-13710	49	21	of	of	ADP
ecj-13710	49	22	oral	oral	ADJ
ecj-13710	49	23	hydrocortisone	hydrocortisone	NOUN
ecj-13710	49	24	.	.	PUNCT
ecj-13710	50	1	a	a	DET
ecj-13710	50	2	follow	follow	VERB
ecj-13710	50	3	-	-	PUNCT
ecj-13710	50	4	up	up	ADP
ecj-13710	50	5	evaluation	evaluation	NOUN
ecj-13710	50	6	three	three	NUM
ecj-13710	50	7	weeks	week	NOUN
ecj-13710	50	8	later	later	ADV
ecj-13710	50	9	confirmed	confirm	VERB
ecj-13710	50	10	a	a	DET
ecj-13710	50	11	return	return	NOUN
ecj-13710	50	12	to	to	ADP
ecj-13710	50	13	baseline	baseline	NOUN
ecj-13710	50	14	creatinine	creatinine	NOUN
ecj-13710	50	15	levels	level	NOUN
ecj-13710	50	16	(	(	PUNCT
ecj-13710	50	17	~1.01	~1.01	NUM
ecj-13710	50	18	mg	mg	PROPN
ecj-13710	50	19	/	/	SYM
ecj-13710	50	20	dl	dl	NOUN
ecj-13710	50	21	)	)	PUNCT
ecj-13710	50	22	and	and	CCONJ
ecj-13710	50	23	complete	complete	ADJ
ecj-13710	50	24	resolution	resolution	NOUN
ecj-13710	50	25	of	of	ADP
ecj-13710	50	26	nagma	nagma	NOUN
ecj-13710	50	27	and	and	CCONJ
ecj-13710	50	28	hyperkalemia	hyperkalemia	NOUN
ecj-13710	50	29	.	.	PUNCT
ecj-13710	51	1	discussion	discussion	NOUN
ecj-13710	51	2	hyperkalemia	hyperkalemia	NOUN
ecj-13710	51	3	is	be	AUX
ecj-13710	51	4	one	one	NUM
ecj-13710	51	5	of	of	ADP
ecj-13710	51	6	the	the	DET
ecj-13710	51	7	most	most	ADV
ecj-13710	51	8	frequently	frequently	ADV
ecj-13710	51	9	encountered	encounter	VERB
ecj-13710	51	10	electrolyte	electrolyte	ADJ
ecj-13710	51	11	disturbances	disturbance	NOUN
ecj-13710	51	12	in	in	ADP
ecj-13710	51	13	hospitalized	hospitalize	VERB
ecj-13710	51	14	patients	patient	NOUN
ecj-13710	51	15	,	,	PUNCT
ecj-13710	51	16	with	with	ADP
ecj-13710	51	17	causes	cause	NOUN
ecj-13710	51	18	broadly	broadly	ADV
ecj-13710	51	19	classified	classify	VERB
ecj-13710	51	20	into	into	ADP
ecj-13710	51	21	increased	increase	VERB
ecj-13710	51	22	potassium	potassium	NOUN
ecj-13710	51	23	intake	intake	NOUN
ecj-13710	51	24	,	,	PUNCT
ecj-13710	51	25	impaired	impaired	ADJ
ecj-13710	51	26	renal	renal	ADJ
ecj-13710	51	27	excretion	excretion	NOUN
ecj-13710	51	28	,	,	PUNCT
ecj-13710	51	29	transcellular	transcellular	NOUN
ecj-13710	51	30	shifts	shift	NOUN
ecj-13710	51	31	,	,	PUNCT
ecj-13710	51	32	or	or	CCONJ
ecj-13710	51	33	pseudohyperkalemia	pseudohyperkalemia	NOUN
ecj-13710	51	34	.	.	PUNCT
ecj-13710	52	1	when	when	SCONJ
ecj-13710	52	2	hyperkalemia	hyperkalemia	NOUN
ecj-13710	52	3	persists	persist	VERB
ecj-13710	52	4	in	in	ADP
ecj-13710	52	5	the	the	DET
ecj-13710	52	6	absence	absence	NOUN
ecj-13710	52	7	of	of	ADP
ecj-13710	52	8	an	an	DET
ecj-13710	52	9	obvious	obvious	ADJ
ecj-13710	52	10	cause	cause	NOUN
ecj-13710	52	11	,	,	PUNCT
ecj-13710	52	12	hypoaldosteronism	hypoaldosteronism	NOUN
ecj-13710	52	13	should	should	AUX
ecj-13710	52	14	be	be	AUX
ecj-13710	52	15	considered	consider	VERB
ecj-13710	52	16	a	a	DET
ecj-13710	52	17	primary	primary	ADJ
ecj-13710	52	18	etiology	etiology	NOUN
ecj-13710	52	19	.	.	PUNCT
ecj-13710	53	1	hypoaldosteronism	hypoaldosteronism	PROPN
ecj-13710	53	2	may	may	AUX
ecj-13710	53	3	arise	arise	VERB
ecj-13710	53	4	from	from	ADP
ecj-13710	53	5	either	either	CCONJ
ecj-13710	53	6	true	true	ADJ
ecj-13710	53	7	aldosterone	aldosterone	NOUN
ecj-13710	53	8	deficiency	deficiency	NOUN
ecj-13710	53	9	or	or	CCONJ
ecj-13710	53	10	aldosterone	aldosterone	NOUN
ecj-13710	53	11	resistance	resistance	NOUN
ecj-13710	53	12	,	,	PUNCT
ecj-13710	53	13	both	both	PRON
ecj-13710	53	14	of	of	ADP
ecj-13710	53	15	which	which	PRON
ecj-13710	53	16	impair	impair	VERB
ecj-13710	53	17	renal	renal	ADJ
ecj-13710	53	18	potassium	potassium	NOUN
ecj-13710	53	19	excretion	excretion	NOUN
ecj-13710	53	20	.	.	PUNCT
ecj-13710	54	1	type	type	NOUN
ecj-13710	54	2	4	4	NUM
ecj-13710	54	3	rta	rta	PROPN
ecj-13710	54	4	falls	fall	NOUN
ecj-13710	54	5	under	under	ADP
ecj-13710	54	6	this	this	DET
ecj-13710	54	7	category	category	NOUN
ecj-13710	54	8	and	and	CCONJ
ecj-13710	54	9	should	should	AUX
ecj-13710	54	10	be	be	AUX
ecj-13710	54	11	included	include	VERB
ecj-13710	54	12	in	in	ADP
ecj-13710	54	13	the	the	DET
ecj-13710	54	14	initial	initial	ADJ
ecj-13710	54	15	diagnostic	diagnostic	ADJ
ecj-13710	54	16	workup	workup	NOUN
ecj-13710	54	17	for	for	ADP
ecj-13710	54	18	unexplained	unexplained	ADJ
ecj-13710	54	19	hyperkalemia	hyperkalemia	NOUN
ecj-13710	54	20	.	.	PUNCT
ecj-13710	55	1	the	the	DET
ecj-13710	55	2	pathophysiology	pathophysiology	NOUN
ecj-13710	55	3	of	of	ADP
ecj-13710	55	4	type	type	NOUN
ecj-13710	55	5	4	4	NUM
ecj-13710	55	6	rta	rta	NOUN
ecj-13710	55	7	is	be	AUX
ecj-13710	55	8	characterized	characterize	VERB
ecj-13710	55	9	by	by	ADP
ecj-13710	55	10	hyperkalemia	hyperkalemia	NOUN
ecj-13710	55	11	and	and	CCONJ
ecj-13710	55	12	nagma	nagma	NOUN
ecj-13710	55	13	,	,	PUNCT
ecj-13710	55	14	primarily	primarily	ADV
ecj-13710	55	15	due	due	ADP
ecj-13710	55	16	to	to	ADP
ecj-13710	55	17	hypoaldosteronism	hypoaldosteronism	NOUN
ecj-13710	55	18	,	,	PUNCT
ecj-13710	55	19	which	which	PRON
ecj-13710	55	20	is	be	AUX
ecj-13710	55	21	more	more	ADV
ecj-13710	55	22	commonly	commonly	ADV
ecj-13710	55	23	observed	observe	VERB
ecj-13710	55	24	than	than	SCONJ
ecj-13710	55	25	aldosterone	aldosterone	NOUN
ecj-13710	55	26	resistance.1	resistance.1	NOUN
ecj-13710	55	27	hypoaldosteronism	hypoaldosteronism	NOUN
ecj-13710	55	28	can	can	AUX
ecj-13710	55	29	be	be	AUX
ecj-13710	55	30	either	either	CCONJ
ecj-13710	55	31	acquired	acquire	VERB
ecj-13710	55	32	(	(	PUNCT
ecj-13710	55	33	secondary	secondary	ADJ
ecj-13710	55	34	mineralocorticoid	mineralocorticoid	NOUN
ecj-13710	55	35	deficiency	deficiency	NOUN
ecj-13710	55	36	)	)	PUNCT
ecj-13710	55	37	or	or	CCONJ
ecj-13710	55	38	,	,	PUNCT
ecj-13710	55	39	less	less	ADV
ecj-13710	55	40	frequently	frequently	ADV
ecj-13710	55	41	,	,	PUNCT
ecj-13710	55	42	inherited	inherit	VERB
ecj-13710	55	43	(	(	PUNCT
ecj-13710	55	44	primary	primary	ADJ
ecj-13710	55	45	mineralocorticoid	mineralocorticoid	NOUN
ecj-13710	55	46	deficiency	deficiency	NOUN
ecj-13710	55	47	)	)	PUNCT
ecj-13710	55	48	.	.	PUNCT
ecj-13710	56	1	the	the	DET
ecj-13710	56	2	most	most	ADV
ecj-13710	56	3	prevalent	prevalent	ADJ
ecj-13710	56	4	cause	cause	NOUN
ecj-13710	56	5	of	of	ADP
ecj-13710	56	6	secondary	secondary	ADJ
ecj-13710	56	7	mineralocorticoid	mineralocorticoid	NOUN
ecj-13710	56	8	deficiency	deficiency	NOUN
ecj-13710	56	9	is	be	AUX
ecj-13710	56	10	hyporeninemic	hyporeninemic	ADJ
ecj-13710	56	11	hypoaldosteronism	hypoaldosteronism	NOUN
ecj-13710	56	12	(	(	PUNCT
ecj-13710	56	13	hh	hh	PROPN
ecj-13710	56	14	)	)	PUNCT
ecj-13710	56	15	,	,	PUNCT
ecj-13710	56	16	frequently	frequently	ADV
ecj-13710	56	17	associated	associate	VERB
ecj-13710	56	18	with	with	ADP
ecj-13710	56	19	dm2	dm2	PROPN
ecj-13710	56	20	and	and	CCONJ
ecj-13710	56	21	certain	certain	ADJ
ecj-13710	56	22	medications	medication	NOUN
ecj-13710	56	23	that	that	PRON
ecj-13710	56	24	interfere	interfere	VERB
ecj-13710	56	25	with	with	ADP
ecj-13710	56	26	the	the	DET
ecj-13710	56	27	raas.2	raas.2	ADJ
ecj-13710	56	28	these	these	PRON
ecj-13710	56	29	include	include	VERB
ecj-13710	56	30	drugs	drug	NOUN
ecj-13710	56	31	that	that	PRON
ecj-13710	56	32	suppress	suppress	VERB
ecj-13710	56	33	renin	renin	ADJ
ecj-13710	56	34	synthesis	synthesis	NOUN
ecj-13710	56	35	,	,	PUNCT
ecj-13710	56	36	such	such	ADJ
ecj-13710	56	37	as	as	ADP
ecj-13710	56	38	nsaids	nsaid	NOUN
ecj-13710	56	39	,	,	PUNCT
ecj-13710	56	40	nonselective	nonselective	ADJ
ecj-13710	56	41	beta	beta	NOUN
ecj-13710	56	42	-	-	PUNCT
ecj-13710	56	43	blockers	blocker	NOUN
ecj-13710	56	44	,	,	PUNCT
ecj-13710	56	45	and	and	CCONJ
ecj-13710	56	46	calcineurin	calcineurin	ADJ
ecj-13710	56	47	inhibitors	inhibitor	NOUN
ecj-13710	56	48	,	,	PUNCT
ecj-13710	56	49	especially	especially	ADV
ecj-13710	56	50	agents	agent	NOUN
ecj-13710	56	51	that	that	PRON
ecj-13710	56	52	directly	directly	ADV
ecj-13710	56	53	inhibit	inhibit	VERB
ecj-13710	56	54	aldosterone	aldosterone	NOUN
ecj-13710	56	55	production	production	NOUN
ecj-13710	56	56	,	,	PUNCT
ecj-13710	56	57	such	such	ADJ
ecj-13710	56	58	as	as	ADP
ecj-13710	56	59	heparin	heparin	NOUN
ecj-13710	56	60	,	,	PUNCT
ecj-13710	56	61	ace	ace	VERB
ecj-13710	56	62	inhibitors	inhibitor	NOUN
ecj-13710	56	63	,	,	PUNCT
ecj-13710	56	64	arbs	arb	NOUN
ecj-13710	56	65	,	,	PUNCT
ecj-13710	56	66	and	and	CCONJ
ecj-13710	56	67	renin	renin	ADJ
ecj-13710	56	68	inhibitors	inhibitor	NOUN
ecj-13710	56	69	(	(	PUNCT
ecj-13710	56	70	e.g.	e.g.	ADV
ecj-13710	56	71	,	,	PUNCT
ecj-13710	56	72	aliskiren).3	aliskiren).3	ADV
ecj-13710	56	73	although	although	SCONJ
ecj-13710	56	74	most	most	ADJ
ecj-13710	56	75	patients	patient	NOUN
ecj-13710	56	76	with	with	ADP
ecj-13710	56	77	hh	hh	PROPN
ecj-13710	56	78	are	be	AUX
ecj-13710	56	79	asymptomatic	asymptomatic	ADJ
ecj-13710	56	80	and	and	CCONJ
ecj-13710	56	81	present	present	ADJ
ecj-13710	56	82	with	with	ADP
ecj-13710	56	83	mild	mild	ADJ
ecj-13710	56	84	to	to	ADP
ecj-13710	56	85	moderate	moderate	ADJ
ecj-13710	56	86	hyperkalemia	hyperkalemia	NOUN
ecj-13710	56	87	,	,	PUNCT
ecj-13710	56	88	the	the	DET
ecj-13710	56	89	condition	condition	NOUN
ecj-13710	56	90	may	may	AUX
ecj-13710	56	91	become	become	VERB
ecj-13710	56	92	clinically	clinically	ADV
ecj-13710	56	93	significant	significant	ADJ
ecj-13710	56	94	when	when	SCONJ
ecj-13710	56	95	additional	additional	ADJ
ecj-13710	56	96	precipitating	precipitating	NOUN
ecj-13710	56	97	factors	factor	NOUN
ecj-13710	56	98	further	far	ADV
ecj-13710	56	99	disrupt	disrupt	VERB
ecj-13710	56	100	potassium	potassium	NOUN
ecj-13710	56	101	homeostasis.2	homeostasis.2	NOUN
ecj-13710	56	102	these	these	DET
ecj-13710	56	103	factors	factor	NOUN
ecj-13710	56	104	include	include	VERB
ecj-13710	56	105	acute	acute	ADJ
ecj-13710	56	106	kidney	kidney	NOUN
ecj-13710	56	107	injury	injury	NOUN
ecj-13710	56	108	,	,	PUNCT
ecj-13710	56	109	salt	salt	NOUN
ecj-13710	56	110	restriction	restriction	NOUN
ecj-13710	56	111	,	,	PUNCT
ecj-13710	56	112	or	or	CCONJ
ecj-13710	56	113	medications	medication	NOUN
ecj-13710	56	114	such	such	ADJ
ecj-13710	56	115	as	as	ADP
ecj-13710	56	116	ace	ace	NOUN
ecj-13710	56	117	inhibitors	inhibitor	NOUN
ecj-13710	56	118	,	,	PUNCT
ecj-13710	56	119	arbs	arb	NOUN
ecj-13710	56	120	,	,	PUNCT
ecj-13710	56	121	potassium	potassium	NOUN
ecj-13710	56	122	-	-	PUNCT
ecj-13710	56	123	sparing	spare	VERB
ecj-13710	56	124	diuretics	diuretic	NOUN
ecj-13710	56	125	,	,	PUNCT
ecj-13710	56	126	or	or	CCONJ
ecj-13710	56	127	heparin.4	heparin.4	NOUN
ecj-13710	56	128	in	in	ADP
ecj-13710	56	129	this	this	DET
ecj-13710	56	130	case	case	NOUN
ecj-13710	56	131	report	report	NOUN
ecj-13710	56	132	,	,	PUNCT
ecj-13710	56	133	we	we	PRON
ecj-13710	56	134	describe	describe	VERB
ecj-13710	56	135	a	a	DET
ecj-13710	56	136	male	male	ADJ
ecj-13710	56	137	patient	patient	NOUN
ecj-13710	56	138	with	with	ADP
ecj-13710	56	139	dm2	dm2	PROPN
ecj-13710	56	140	who	who	PRON
ecj-13710	56	141	developed	develop	VERB
ecj-13710	56	142	type	type	NOUN
ecj-13710	56	143	4	4	NUM
ecj-13710	56	144	rta	rta	NOUN
ecj-13710	56	145	following	follow	VERB
ecj-13710	56	146	the	the	DET
ecj-13710	56	147	initiation	initiation	NOUN
ecj-13710	56	148	of	of	ADP
ecj-13710	56	149	telmisartan	telmisartan	NOUN
ecj-13710	56	150	,	,	PUNCT
ecj-13710	56	151	an	an	DET
ecj-13710	56	152	arb	arb	NOUN
ecj-13710	56	153	commonly	commonly	ADV
ecj-13710	56	154	used	use	VERB
ecj-13710	56	155	in	in	ADP
ecj-13710	56	156	clinical	clinical	ADJ
ecj-13710	56	157	practice	practice	NOUN
ecj-13710	56	158	.	.	PUNCT
ecj-13710	57	1	although	although	SCONJ
ecj-13710	57	2	type	type	NOUN
ecj-13710	57	3	4	4	NUM
ecj-13710	57	4	rta	rta	NOUN
ecj-13710	57	5	is	be	AUX
ecj-13710	57	6	a	a	DET
ecj-13710	57	7	recognized	recognize	VERB
ecj-13710	57	8	side	side	NOUN
ecj-13710	57	9	effect	effect	NOUN
ecj-13710	57	10	of	of	ADP
ecj-13710	57	11	raas	raas	NOUN
ecj-13710	57	12	inhibitors	inhibitor	NOUN
ecj-13710	57	13	,	,	PUNCT
ecj-13710	57	14	detailed	detailed	ADJ
ecj-13710	57	15	case	case	NOUN
ecj-13710	57	16	reports	report	VERB
ecj-13710	57	17	specifically	specifically	ADV
ecj-13710	57	18	linking	link	VERB
ecj-13710	57	19	telmisartan	telmisartan	NOUN
ecj-13710	57	20	to	to	PART
ecj-13710	57	21	type	type	VERB
ecj-13710	57	22	4	4	NUM
ecj-13710	57	23	rta	rta	NOUN
ecj-13710	57	24	are	be	AUX
ecj-13710	57	25	limited	limit	VERB
ecj-13710	57	26	in	in	ADP
ecj-13710	57	27	the	the	DET
ecj-13710	57	28	literature	literature	NOUN
ecj-13710	57	29	.	.	PUNCT
ecj-13710	58	1	the	the	DET
ecj-13710	58	2	pathophysiological	pathophysiological	ADJ
ecj-13710	58	3	basis	basis	NOUN
ecj-13710	58	4	of	of	ADP
ecj-13710	58	5	type	type	NOUN
ecj-13710	58	6	4	4	NUM
ecj-13710	58	7	rta	rta	NOUN
ecj-13710	58	8	involves	involve	VERB
ecj-13710	58	9	impaired	impaired	ADJ
ecj-13710	58	10	aldosterone	aldosterone	NOUN
ecj-13710	58	11	activity	activity	NOUN
ecj-13710	58	12	,	,	PUNCT
ecj-13710	58	13	which	which	PRON
ecj-13710	58	14	leads	lead	VERB
ecj-13710	58	15	to	to	ADP
ecj-13710	58	16	reduced	reduced	ADJ
ecj-13710	58	17	sodium	sodium	NOUN
ecj-13710	58	18	(	(	PUNCT
ecj-13710	58	19	na⁺	na⁺	NOUN
ecj-13710	58	20	)	)	PUNCT
ecj-13710	58	21	reabsorption	reabsorption	NOUN
ecj-13710	58	22	in	in	ADP
ecj-13710	58	23	the	the	DET
ecj-13710	58	24	distal	distal	ADJ
ecj-13710	58	25	nephron	nephron	NOUN
ecj-13710	58	26	.	.	PUNCT
ecj-13710	59	1	this	this	PRON
ecj-13710	59	2	,	,	PUNCT
ecj-13710	59	3	in	in	ADP
ecj-13710	59	4	turn	turn	NOUN
ecj-13710	59	5	,	,	PUNCT
ecj-13710	59	6	diminishes	diminish	VERB
ecj-13710	59	7	the	the	DET
ecj-13710	59	8	electrochemical	electrochemical	ADJ
ecj-13710	59	9	gradient	gradient	NOUN
ecj-13710	59	10	required	require	VERB
ecj-13710	59	11	for	for	ADP
ecj-13710	59	12	potassium	potassium	NOUN
ecj-13710	59	13	(	(	PUNCT
ecj-13710	59	14	k⁺	k⁺	PROPN
ecj-13710	59	15	)	)	PUNCT
ecj-13710	59	16	and	and	CCONJ
ecj-13710	59	17	hydrogen	hydrogen	PROPN
ecj-13710	59	18	(	(	PUNCT
ecj-13710	59	19	h⁺	h⁺	PROPN
ecj-13710	59	20	)	)	PUNCT
ecj-13710	59	21	excretion	excretion	NOUN
ecj-13710	59	22	,	,	PUNCT
ecj-13710	59	23	resulting	result	VERB
ecj-13710	59	24	in	in	ADP
ecj-13710	59	25	hyperkalemia	hyperkalemia	NOUN
ecj-13710	59	26	and	and	CCONJ
ecj-13710	59	27	metabolic	metabolic	NOUN
ecj-13710	59	28	acidosis	acidosis	NOUN
ecj-13710	59	29	.	.	PUNCT
ecj-13710	60	1	additionally	additionally	ADV
ecj-13710	60	2	,	,	PUNCT
ecj-13710	60	3	hyperkalemia	hyperkalemia	NOUN
ecj-13710	60	4	inhibits	inhibit	VERB
ecj-13710	60	5	renal	renal	ADJ
ecj-13710	60	6	ammonium	ammonium	NOUN
ecj-13710	60	7	(	(	PUNCT
ecj-13710	60	8	nh4⁺	nh4⁺	PROPN
ecj-13710	60	9	)	)	PUNCT
ecj-13710	60	10	production	production	NOUN
ecj-13710	60	11	in	in	ADP
ecj-13710	60	12	the	the	DET
ecj-13710	60	13	proximal	proximal	ADJ
ecj-13710	60	14	tubule	tubule	NOUN
ecj-13710	60	15	,	,	PUNCT
ecj-13710	60	16	further	far	ADV
ecj-13710	60	17	impairing	impair	VERB
ecj-13710	60	18	acid	acid	NOUN
ecj-13710	60	19	excretion	excretion	NOUN
ecj-13710	60	20	and	and	CCONJ
ecj-13710	60	21	exacerbating	exacerbate	VERB
ecj-13710	60	22	acidosis.5	acidosis.5	PROPN
ecj-13710	60	23	key	key	ADJ
ecj-13710	60	24	laboratory	laboratory	NOUN
ecj-13710	60	25	findings	finding	NOUN
ecj-13710	60	26	in	in	ADP
ecj-13710	60	27	this	this	DET
ecj-13710	60	28	patient	patient	NOUN
ecj-13710	60	29	were	be	AUX
ecj-13710	60	30	consistent	consistent	ADJ
ecj-13710	60	31	with	with	ADP
ecj-13710	60	32	a	a	DET
ecj-13710	60	33	diagnosis	diagnosis	NOUN
ecj-13710	60	34	of	of	ADP
ecj-13710	60	35	type	type	NOUN
ecj-13710	60	36	4	4	NUM
ecj-13710	60	37	rta	rta	NOUN
ecj-13710	60	38	.	.	PUNCT
ecj-13710	61	1	these	these	PRON
ecj-13710	61	2	included	include	VERB
ecj-13710	61	3	persistent	persistent	ADJ
ecj-13710	61	4	hyperkalemia	hyperkalemia	NOUN
ecj-13710	61	5	that	that	PRON
ecj-13710	61	6	was	be	AUX
ecj-13710	61	7	disproportionate	disproportionate	ADJ
ecj-13710	61	8	to	to	ADP
ecj-13710	61	9	the	the	DET
ecj-13710	61	10	degree	degree	NOUN
ecj-13710	61	11	of	of	ADP
ecj-13710	61	12	renal	renal	ADJ
ecj-13710	61	13	dysfunction	dysfunction	NOUN
ecj-13710	61	14	and	and	CCONJ
ecj-13710	61	15	potassium	potassium	NOUN
ecj-13710	61	16	intake	intake	NOUN
ecj-13710	61	17	,	,	PUNCT
ecj-13710	61	18	mildly	mildly	ADV
ecj-13710	61	19	reduced	reduce	VERB
ecj-13710	61	20	serum	serum	NOUN
ecj-13710	61	21	bicarbonate	bicarbonate	NOUN
ecj-13710	61	22	,	,	PUNCT
ecj-13710	61	23	nagma	nagma	NOUN
ecj-13710	61	24	,	,	PUNCT
ecj-13710	61	25	and	and	CCONJ
ecj-13710	61	26	a	a	DET
ecj-13710	61	27	positive	positive	ADJ
ecj-13710	61	28	uag	uag	NOUN
ecj-13710	61	29	—	—	PUNCT
ecj-13710	61	30	all	all	DET
ecj-13710	61	31	hallmark	hallmark	ADJ
ecj-13710	61	32	features	feature	NOUN
ecj-13710	61	33	of	of	ADP
ecj-13710	61	34	type	type	NOUN
ecj-13710	61	35	4	4	NUM
ecj-13710	61	36	rta	rta	NOUN
ecj-13710	61	37	.	.	PUNCT
ecj-13710	62	1	in	in	ADP
ecj-13710	62	2	type	type	NOUN
ecj-13710	62	3	4	4	NUM
ecj-13710	62	4	rta	rta	NOUN
ecj-13710	62	5	,	,	PUNCT
ecj-13710	62	6	urine	urine	NOUN
ecj-13710	62	7	ph	ph	NOUN
ecj-13710	62	8	is	be	AUX
ecj-13710	62	9	often	often	ADV
ecj-13710	62	10	still	still	ADV
ecj-13710	62	11	acidic	acidic	ADJ
ecj-13710	62	12	(	(	PUNCT
ecj-13710	62	13	<	<	X
ecj-13710	62	14	5.5	5.5	NUM
ecj-13710	62	15	)	)	PUNCT
ecj-13710	62	16	because	because	SCONJ
ecj-13710	62	17	h⁺	h⁺	PROPN
ecj-13710	62	18	secretion	secretion	NOUN
ecj-13710	62	19	via	via	ADP
ecj-13710	62	20	atp	atp	PROPN
ecj-13710	62	21	-	-	PUNCT
ecj-13710	62	22	dependent	dependent	ADJ
ecj-13710	62	23	proton	proton	NOUN
ecj-13710	62	24	pumps	pump	NOUN
ecj-13710	62	25	in	in	ADP
ecj-13710	62	26	the	the	DET
ecj-13710	62	27	distal	distal	ADJ
ecj-13710	62	28	nephron	nephron	NOUN
ecj-13710	62	29	is	be	AUX
ecj-13710	62	30	partially	partially	ADV
ecj-13710	62	31	preserved	preserve	VERB
ecj-13710	62	32	.	.	PUNCT
ecj-13710	63	1	however	however	ADV
ecj-13710	63	2	,	,	PUNCT
ecj-13710	63	3	the	the	DET
ecj-13710	63	4	overall	overall	ADJ
ecj-13710	63	5	acid	acid	NOUN
ecj-13710	63	6	excretion	excretion	NOUN
ecj-13710	63	7	is	be	AUX
ecj-13710	63	8	impaired	impair	VERB
ecj-13710	63	9	due	due	ADP
ecj-13710	63	10	to	to	ADP
ecj-13710	63	11	reduced	reduce	VERB
ecj-13710	63	12	nh4⁺	nh4⁺	ADJ
ecj-13710	63	13	production	production	NOUN
ecj-13710	63	14	,	,	PUNCT
ecj-13710	63	15	which	which	PRON
ecj-13710	63	16	limits	limit	VERB
ecj-13710	63	17	the	the	DET
ecj-13710	63	18	kidney	kidney	NOUN
ecj-13710	63	19	’s	’s	PART
ecj-13710	63	20	ability	ability	NOUN
ecj-13710	63	21	to	to	PART
ecj-13710	63	22	buffer	buffer	VERB
ecj-13710	63	23	and	and	CCONJ
ecj-13710	63	24	eliminate	eliminate	VERB
ecj-13710	63	25	acid	acid	NOUN
ecj-13710	63	26	effectively	effectively	ADV
ecj-13710	63	27	.	.	PUNCT
ecj-13710	64	1	that	that	PRON
ecj-13710	64	2	said	say	VERB
ecj-13710	64	3	,	,	PUNCT
ecj-13710	64	4	some	some	DET
ecj-13710	64	5	patients	patient	NOUN
ecj-13710	64	6	may	may	AUX
ecj-13710	64	7	initially	initially	ADV
ecj-13710	64	8	present	present	VERB
ecj-13710	64	9	with	with	ADP
ecj-13710	64	10	a	a	DET
ecj-13710	64	11	urine	urine	NOUN
ecj-13710	64	12	ph	ph	VERB
ecj-13710	64	13	>	>	ADP
ecj-13710	64	14	5.5	5.5	NUM
ecj-13710	64	15	,	,	PUNCT
ecj-13710	64	16	especially	especially	ADV
ecj-13710	64	17	early	early	ADV
ecj-13710	64	18	in	in	ADP
ecj-13710	64	19	the	the	DET
ecj-13710	64	20	disease	disease	NOUN
ecj-13710	64	21	course	course	NOUN
ecj-13710	64	22	.	.	PUNCT
ecj-13710	65	1	this	this	PRON
ecj-13710	65	2	can	can	AUX
ecj-13710	65	3	occur	occur	VERB
ecj-13710	65	4	when	when	SCONJ
ecj-13710	65	5	h⁺	h⁺	PROPN
ecj-13710	65	6	secretion	secretion	NOUN
ecj-13710	65	7	is	be	AUX
ecj-13710	65	8	transiently	transiently	ADV
ecj-13710	65	9	impaired	impair	VERB
ecj-13710	65	10	,	,	PUNCT
ecj-13710	65	11	even	even	ADV
ecj-13710	65	12	though	though	SCONJ
ecj-13710	65	13	the	the	DET
ecj-13710	65	14	mechanisms	mechanism	NOUN
ecj-13710	65	15	for	for	ADP
ecj-13710	65	16	acidification	acidification	NOUN
ecj-13710	65	17	are	be	AUX
ecj-13710	65	18	intact	intact	ADJ
ecj-13710	65	19	.	.	PUNCT
ecj-13710	66	1	in	in	ADP
ecj-13710	66	2	our	our	PRON
ecj-13710	66	3	patient	patient	NOUN
ecj-13710	66	4	,	,	PUNCT
ecj-13710	66	5	the	the	DET
ecj-13710	66	6	initial	initial	ADJ
ecj-13710	66	7	urine	urine	NOUN
ecj-13710	66	8	ph	ph	NOUN
ecj-13710	66	9	was	be	AUX
ecj-13710	66	10	6.5	6.5	NUM
ecj-13710	66	11	,	,	PUNCT
ecj-13710	66	12	but	but	CCONJ
ecj-13710	66	13	with	with	ADP
ecj-13710	66	14	progression	progression	NOUN
ecj-13710	66	15	and	and	CCONJ
ecj-13710	66	16	treatment	treatment	NOUN
ecj-13710	66	17	,	,	PUNCT
ecj-13710	66	18	subsequent	subsequent	ADJ
ecj-13710	66	19	measurements	measurement	NOUN
ecj-13710	66	20	showed	show	VERB
ecj-13710	66	21	a	a	DET
ecj-13710	66	22	clear	clear	ADJ
ecj-13710	66	23	acidification	acidification	NOUN
ecj-13710	66	24	trend	trend	NOUN
ecj-13710	66	25	,	,	PUNCT
ecj-13710	66	26	with	with	ADP
ecj-13710	66	27	the	the	DET
ecj-13710	66	28	urine	urine	NOUN
ecj-13710	66	29	ph	ph	NOUN
ecj-13710	66	30	ultimately	ultimately	ADV
ecj-13710	66	31	decreasing	decrease	VERB
ecj-13710	66	32	to	to	ADP
ecj-13710	66	33	5.5	5.5	NUM
ecj-13710	66	34	,	,	PUNCT
ecj-13710	66	35	which	which	PRON
ecj-13710	66	36	signifies	signify	VERB
ecj-13710	66	37	the	the	DET
ecj-13710	66	38	patient	patient	NOUN
ecj-13710	66	39	’s	’s	PART
ecj-13710	66	40	ability	ability	NOUN
ecj-13710	66	41	to	to	PART
ecj-13710	66	42	acidify	acidify	VERB
ecj-13710	66	43	urine	urine	NOUN
ecj-13710	66	44	.	.	PUNCT
ecj-13710	67	1	patients	patient	NOUN
ecj-13710	67	2	with	with	ADP
ecj-13710	67	3	diabetes	diabetes	NOUN
ecj-13710	67	4	mellitus	mellitus	NOUN
ecj-13710	67	5	are	be	AUX
ecj-13710	67	6	particularly	particularly	ADV
ecj-13710	67	7	vulnerable	vulnerable	ADJ
ecj-13710	67	8	to	to	ADP
ecj-13710	67	9	type	type	NOUN
ecj-13710	67	10	4	4	NUM
ecj-13710	67	11	rta	rta	NOUN
ecj-13710	67	12	due	due	ADP
ecj-13710	67	13	to	to	ADP
ecj-13710	67	14	dysregulation	dysregulation	NOUN
ecj-13710	67	15	of	of	ADP
ecj-13710	67	16	the	the	DET
ecj-13710	67	17	raas	raas	NOUN
ecj-13710	67	18	,	,	PUNCT
ecj-13710	67	19	increasing	increase	VERB
ecj-13710	67	20	their	their	PRON
ecj-13710	67	21	risk	risk	NOUN
ecj-13710	67	22	of	of	ADP
ecj-13710	67	23	hyperkalemia.6	hyperkalemia.6	PROPN
ecj-13710	67	24	the	the	DET
ecj-13710	67	25	introduction	introduction	NOUN
ecj-13710	67	26	of	of	ADP
ecj-13710	67	27	raas	raas	NOUN
ecj-13710	67	28	inhibitors	inhibitor	NOUN
ecj-13710	67	29	,	,	PUNCT
ecj-13710	67	30	such	such	ADJ
ecj-13710	67	31	as	as	ADP
ecj-13710	67	32	arbs	arb	NOUN
ecj-13710	67	33	,	,	PUNCT
ecj-13710	67	34	can	can	AUX
ecj-13710	67	35	further	far	ADV
ecj-13710	67	36	aggravate	aggravate	VERB
ecj-13710	67	37	this	this	DET
ecj-13710	67	38	imbalance	imbalance	NOUN
ecj-13710	67	39	,	,	PUNCT
ecj-13710	67	40	potentially	potentially	ADV
ecj-13710	67	41	triggering	trigger	VERB
ecj-13710	67	42	type	type	NOUN
ecj-13710	67	43	4	4	NUM
ecj-13710	67	44	rta	rta	NOUN
ecj-13710	67	45	,	,	PUNCT
ecj-13710	67	46	as	as	SCONJ
ecj-13710	67	47	observed	observe	VERB
ecj-13710	67	48	in	in	ADP
ecj-13710	67	49	this	this	DET
ecj-13710	67	50	case	case	NOUN
ecj-13710	67	51	.	.	PUNCT
ecj-13710	68	1	notably	notably	ADV
ecj-13710	68	2	,	,	PUNCT
ecj-13710	68	3	the	the	DET
ecj-13710	68	4	patient	patient	NOUN
ecj-13710	68	5	achieved	achieve	VERB
ecj-13710	68	6	normokalemia	normokalemia	NOUN
ecj-13710	68	7	and	and	CCONJ
ecj-13710	68	8	a	a	DET
ecj-13710	68	9	return	return	NOUN
ecj-13710	68	10	to	to	ADP
ecj-13710	68	11	baseline	baseline	NOUN
ecj-13710	68	12	creatinine	creatinine	NOUN
ecj-13710	68	13	levels	level	NOUN
ecj-13710	68	14	shortly	shortly	ADV
ecj-13710	68	15	after	after	ADP
ecj-13710	68	16	discontinuing	discontinue	VERB
ecj-13710	68	17	telmisartan	telmisartan	NOUN
ecj-13710	68	18	and	and	CCONJ
ecj-13710	68	19	initiating	initiate	VERB
ecj-13710	68	20	hydrocortisone	hydrocortisone	NOUN
ecj-13710	68	21	(	(	PUNCT
ecj-13710	68	22	200	200	NUM
ecj-13710	68	23	mg	mg	NUM
ecj-13710	68	24	/	/	SYM
ecj-13710	68	25	day	day	NOUN
ecj-13710	68	26	)	)	PUNCT
ecj-13710	68	27	.	.	PUNCT
ecj-13710	69	1	this	this	DET
ecj-13710	69	2	outcome	outcome	NOUN
ecj-13710	69	3	is	be	AUX
ecj-13710	69	4	particularly	particularly	ADV
ecj-13710	69	5	significant	significant	ADJ
ecj-13710	69	6	,	,	PUNCT
ecj-13710	69	7	as	as	SCONJ
ecj-13710	69	8	type	type	NOUN
ecj-13710	69	9	4	4	NUM
ecj-13710	69	10	rta	rta	NOUN
ecj-13710	69	11	is	be	AUX
ecj-13710	69	12	conventionally	conventionally	ADV
ecj-13710	69	13	managed	manage	VERB
ecj-13710	69	14	with	with	ADP
ecj-13710	69	15	fludrocortisone	fludrocortisone	NOUN
ecj-13710	69	16	to	to	PART
ecj-13710	69	17	correct	correct	VERB
ecj-13710	69	18	aldosterone	aldosterone	NOUN
ecj-13710	69	19	deficiency.7	deficiency.7	VERB
ecj-13710	69	20	the	the	DET
ecj-13710	69	21	successful	successful	ADJ
ecj-13710	69	22	use	use	NOUN
ecj-13710	69	23	of	of	ADP
ecj-13710	69	24	hydrocortisone	hydrocortisone	NOUN
ecj-13710	69	25	in	in	ADP
ecj-13710	69	26	this	this	DET
ecj-13710	69	27	case	case	NOUN
ecj-13710	69	28	suggests	suggest	VERB
ecj-13710	69	29	its	its	PRON
ecj-13710	69	30	potential	potential	ADJ
ecj-13710	69	31	role	role	NOUN
ecj-13710	69	32	as	as	ADP
ecj-13710	69	33	a	a	DET
ecj-13710	69	34	therapeutic	therapeutic	ADJ
ecj-13710	69	35	alternative	alternative	NOUN
ecj-13710	69	36	when	when	SCONJ
ecj-13710	69	37	fludrocortisone	fludrocortisone	NOUN
ecj-13710	69	38	is	be	AUX
ecj-13710	69	39	unavailable	unavailable	ADJ
ecj-13710	69	40	.	.	PUNCT
ecj-13710	70	1	the	the	DET
ecj-13710	70	2	primary	primary	ADJ
ecj-13710	70	3	limitation	limitation	NOUN
ecj-13710	70	4	of	of	ADP
ecj-13710	70	5	this	this	DET
ecj-13710	70	6	case	case	NOUN
ecj-13710	70	7	report	report	NOUN
ecj-13710	70	8	is	be	AUX
ecj-13710	70	9	the	the	DET
ecj-13710	70	10	inability	inability	NOUN
ecj-13710	70	11	to	to	PART
ecj-13710	70	12	perform	perform	VERB
ecj-13710	70	13	a	a	DET
ecj-13710	70	14	more	more	ADV
ecj-13710	70	15	comprehensive	comprehensive	ADJ
ecj-13710	70	16	diagnostic	diagnostic	ADJ
ecj-13710	70	17	workup	workup	NOUN
ecj-13710	70	18	,	,	PUNCT
ecj-13710	70	19	such	such	ADJ
ecj-13710	70	20	as	as	ADP
ecj-13710	70	21	measuring	measure	VERB
ecj-13710	70	22	aldosterone	aldosterone	NOUN
ecj-13710	70	23	levels	level	NOUN
ecj-13710	70	24	or	or	CCONJ
ecj-13710	70	25	calculating	calculate	VERB
ecj-13710	70	26	the	the	DET
ecj-13710	70	27	urine	urine	NOUN
ecj-13710	70	28	osmolal	osmolal	NOUN
ecj-13710	70	29	gap	gap	NOUN
ecj-13710	70	30	,	,	PUNCT
ecj-13710	70	31	due	due	ADP
ecj-13710	70	32	to	to	ADP
ecj-13710	70	33	temporary	temporary	ADJ
ecj-13710	70	34	limitations	limitation	NOUN
ecj-13710	70	35	in	in	ADP
ecj-13710	70	36	local	local	ADJ
ecj-13710	70	37	laboratory	laboratory	NOUN
ecj-13710	70	38	resources	resource	NOUN
ecj-13710	70	39	.	.	PUNCT
ecj-13710	71	1	references	reference	NOUN
ecj-13710	71	2	1	1	NUM
ecj-13710	71	3	.	.	PUNCT
ecj-13710	72	1	phelps	phelps	PROPN
ecj-13710	72	2	kr	kr	PROPN
ecj-13710	72	3	,	,	PUNCT
ecj-13710	72	4	lieberman	lieberman	PROPN
ecj-13710	72	5	rl	rl	PROPN
ecj-13710	72	6	,	,	PUNCT
ecj-13710	72	7	oh	oh	INTJ
ecj-13710	72	8	ms	ms	NOUN
ecj-13710	72	9	,	,	PUNCT
ecj-13710	72	10	et	et	PROPN
ecj-13710	72	11	al	al	PROPN
ecj-13710	72	12	.	.	PROPN
ecj-13710	72	13	pathophysiology	pathophysiology	NOUN
ecj-13710	72	14	of	of	ADP
ecj-13710	72	15	the	the	DET
ecj-13710	72	16	syndrome	syndrome	NOUN
ecj-13710	72	17	of	of	ADP
ecj-13710	72	18	hyporeninemic	hyporeninemic	ADJ
ecj-13710	72	19	hypoaldosteronism	hypoaldosteronism	NOUN
ecj-13710	72	20	.	.	PUNCT
ecj-13710	73	1	metabolism	metabolism	NOUN
ecj-13710	73	2	1980;29:186–99	1980;29:186–99	NUM
ecj-13710	73	3	.	.	PUNCT
ecj-13710	74	1	2	2	NUM
ecj-13710	74	2	.	.	X
ecj-13710	74	3	sousa	sousa	PROPN
ecj-13710	74	4	agp	agp	PROPN
ecj-13710	74	5	,	,	PUNCT
ecj-13710	74	6	cabral	cabral	PROPN
ecj-13710	74	7	jv	jv	PROPN
ecj-13710	74	8	de	de	PROPN
ecj-13710	74	9	s	s	PROPN
ecj-13710	74	10	,	,	PUNCT
ecj-13710	74	11	el	el	PROPN
ecj-13710	74	12	-	-	PROPN
ecj-13710	74	13	feghaly	feghaly	PROPN
ecj-13710	74	14	wb	wb	PROPN
ecj-13710	74	15	,	,	PUNCT
ecj-13710	74	16	et	et	PROPN
ecj-13710	74	17	al	al	PROPN
ecj-13710	74	18	.	.	PUNCT
ecj-13710	74	19	case	case	NOUN
ecj-13710	74	20	report	report	NOUN
ecj-13710	74	21	[	[	X
ecj-13710	74	22	emergency	emergency	NOUN
ecj-13710	74	23	care	care	NOUN
ecj-13710	74	24	journal	journal	NOUN
ecj-13710	74	25	2025	2025	NUM
ecj-13710	74	26	;	;	PUNCT
ecj-13710	75	1	21:13710	21:13710	NUM
ecj-13710	75	2	]	]	X
ecj-13710	76	1	[	[	X
ecj-13710	76	2	page	page	NOUN
ecj-13710	76	3	31	31	NUM
ecj-13710	76	4	]	]	PUNCT
ecj-13710	76	5	hyporeninemic	hyporeninemic	ADJ
ecj-13710	76	6	hypoaldosteronism	hypoaldosteronism	NOUN
ecj-13710	76	7	and	and	CCONJ
ecj-13710	76	8	diabetes	diabetes	NOUN
ecj-13710	76	9	mellitus	mellitus	NOUN
ecj-13710	76	10	:	:	PUNCT
ecj-13710	76	11	pathophysiology	pathophysiology	NOUN
ecj-13710	76	12	assumptions	assumption	NOUN
ecj-13710	76	13	,	,	PUNCT
ecj-13710	76	14	clinical	clinical	ADJ
ecj-13710	76	15	aspects	aspect	NOUN
ecj-13710	76	16	and	and	CCONJ
ecj-13710	76	17	implications	implication	NOUN
ecj-13710	76	18	for	for	ADP
ecj-13710	76	19	management	management	NOUN
ecj-13710	76	20	.	.	PUNCT
ecj-13710	77	1	world	world	PROPN
ecj-13710	77	2	j	j	PROPN
ecj-13710	77	3	diabetes	diabete	VERB
ecj-13710	77	4	2016;7:101–11	2016;7:101–11	NUM
ecj-13710	77	5	.	.	PUNCT
ecj-13710	78	1	3	3	X
ecj-13710	78	2	.	.	X
ecj-13710	78	3	farkas	farkas	PROPN
ecj-13710	78	4	j.	j.	PROPN
ecj-13710	78	5	non	non	PROPN
ecj-13710	78	6	-	-	ADJ
ecj-13710	78	7	anion	anion	ADJ
ecj-13710	78	8	-	-	PUNCT
ecj-13710	78	9	gap	gap	NOUN
ecj-13710	78	10	metabolic	metabolic	NOUN
ecj-13710	78	11	acidosis	acidosis	NOUN
ecj-13710	78	12	(	(	PUNCT
ecj-13710	78	13	nagma	nagma	NOUN
ecj-13710	78	14	)	)	PUNCT
ecj-13710	78	15	.	.	PUNCT
ecj-13710	79	1	emcrit	emcrit	PROPN
ecj-13710	79	2	project	project	PROPN
ecj-13710	79	3	.	.	PUNCT
ecj-13710	80	1	available	available	ADJ
ecj-13710	80	2	from	from	ADP
ecj-13710	80	3	:	:	PUNCT
ecj-13710	80	4	https://emcrit.org/ibcc/nagma/	https://emcrit.org/ibcc/nagma/	PROPN
ecj-13710	80	5	4	4	NUM
ecj-13710	80	6	.	.	PROPN
ecj-13710	80	7	galbiati	galbiati	PROPN
ecj-13710	80	8	f.	f.	PROPN
ecj-13710	80	9	type	type	PROPN
ecj-13710	80	10	iv	iv	VERB
ecj-13710	80	11	rta	rta	PROPN
ecj-13710	80	12	in	in	ADP
ecj-13710	80	13	chronic	chronic	ADJ
ecj-13710	80	14	adrenal	adrenal	ADJ
ecj-13710	80	15	insufficiency	insufficiency	NOUN
ecj-13710	80	16	and	and	CCONJ
ecj-13710	80	17	concomitant	concomitant	ADJ
ecj-13710	80	18	lisinopril	lisinopril	NOUN
ecj-13710	80	19	treatment	treatment	NOUN
ecj-13710	80	20	.	.	PUNCT
ecj-13710	81	1	case	case	NOUN
ecj-13710	81	2	rep	rep	PROPN
ecj-13710	81	3	endocrinol	endocrinol	PROPN
ecj-13710	81	4	2020;2020:8897112	2020;2020:8897112	NUM
ecj-13710	81	5	.	.	PUNCT
ecj-13710	82	1	5	5	NUM
ecj-13710	82	2	.	.	X
ecj-13710	82	3	harris	harris	PROPN
ecj-13710	82	4	an	an	PROPN
ecj-13710	82	5	,	,	PUNCT
ecj-13710	82	6	grimm	grimm	NOUN
ecj-13710	82	7	pr	pr	PROPN
ecj-13710	82	8	,	,	PUNCT
ecj-13710	82	9	lee	lee	PROPN
ecj-13710	82	10	hw	hw	PROPN
ecj-13710	82	11	,	,	PUNCT
ecj-13710	82	12	et	et	PROPN
ecj-13710	82	13	al	al	PROPN
ecj-13710	82	14	.	.	PUNCT
ecj-13710	83	1	mechanism	mechanism	NOUN
ecj-13710	83	2	of	of	ADP
ecj-13710	83	3	hyperkalemia	hyperkalemia	NOUN
ecj-13710	83	4	-	-	PUNCT
ecj-13710	83	5	induced	induce	VERB
ecj-13710	83	6	metabolic	metabolic	NOUN
ecj-13710	83	7	acidosis	acidosis	NOUN
ecj-13710	83	8	.	.	PUNCT
ecj-13710	84	1	j	j	PROPN
ecj-13710	84	2	am	be	AUX
ecj-13710	84	3	soc	soc	NOUN
ecj-13710	84	4	nephrol	nephrol	NOUN
ecj-13710	84	5	2018;29:1411	2018;29:1411	NUM
ecj-13710	84	6	.	.	PROPN
ecj-13710	84	7	6	6	NUM
ecj-13710	84	8	.	.	X
ecj-13710	84	9	bello	bello	PROPN
ecj-13710	84	10	chprt	chprt	PROPN
ecj-13710	84	11	,	,	PUNCT
ecj-13710	84	12	duarte	duarte	PROPN
ecj-13710	84	13	js	js	PROPN
ecj-13710	84	14	,	,	PUNCT
ecj-13710	84	15	vasconcelos	vasconcelos	PROPN
ecj-13710	84	16	c	c	PROPN
ecj-13710	84	17	,	,	PUNCT
ecj-13710	84	18	et	et	PROPN
ecj-13710	84	19	al	al	PROPN
ecj-13710	84	20	.	.	PROPN
ecj-13710	85	1	diabetes	diabete	VERB
ecj-13710	85	2	mellitus	mellitus	PROPN
ecj-13710	85	3	and	and	CCONJ
ecj-13710	85	4	hyperkalemic	hyperkalemic	ADJ
ecj-13710	85	5	renal	renal	ADJ
ecj-13710	85	6	tubular	tubular	ADJ
ecj-13710	85	7	acidosis	acidosis	NOUN
ecj-13710	85	8	:	:	PUNCT
ecj-13710	85	9	case	case	NOUN
ecj-13710	85	10	reports	report	NOUN
ecj-13710	85	11	and	and	CCONJ
ecj-13710	85	12	literature	literature	PROPN
ecj-13710	85	13	review	review	PROPN
ecj-13710	85	14	.	.	PUNCT
ecj-13710	86	1	j	j	PROPN
ecj-13710	86	2	bras	bras	PROPN
ecj-13710	86	3	nefrol	nefrol	VERB
ecj-13710	86	4	2017;39:481	2017;39:481	NOUN
ecj-13710	86	5	-	-	SYM
ecj-13710	86	6	5	5	NUM
ecj-13710	86	7	.	.	NOUN
ecj-13710	86	8	7	7	NUM
ecj-13710	86	9	.	.	X
ecj-13710	86	10	palmer	palmer	PROPN
ecj-13710	86	11	bf	bf	PROPN
ecj-13710	86	12	,	,	PUNCT
ecj-13710	86	13	kelepouris	kelepouris	PROPN
ecj-13710	86	14	e	e	PROPN
ecj-13710	86	15	,	,	PUNCT
ecj-13710	86	16	clegg	clegg	PROPN
ecj-13710	86	17	dj	dj	PROPN
ecj-13710	86	18	.	.	PUNCT
ecj-13710	87	1	renal	renal	ADJ
ecj-13710	87	2	tubular	tubular	ADJ
ecj-13710	87	3	acidosis	acidosis	NOUN
ecj-13710	87	4	and	and	CCONJ
ecj-13710	87	5	management	management	NOUN
ecj-13710	87	6	strategies	strategy	NOUN
ecj-13710	87	7	:	:	PUNCT
ecj-13710	87	8	a	a	DET
ecj-13710	87	9	narrative	narrative	NOUN
ecj-13710	87	10	review	review	NOUN
ecj-13710	87	11	.	.	PUNCT
ecj-13710	88	1	adv	adv	INTJ
ecj-13710	88	2	ther	ther	VERB
ecj-13710	88	3	2021;38:949–68	2021;38:949–68	PROPN
ecj-13710	89	1	.	.	PUNCT
ecj-13710	89	2	case	case	NOUN
ecj-13710	89	3	report	report	NOUN
ecj-13710	89	4	[	[	X
ecj-13710	89	5	page	page	NOUN
ecj-13710	89	6	32	32	NUM
ecj-13710	89	7	]	]	PUNCT
ecj-13710	90	1	[	[	X
ecj-13710	90	2	emergency	emergency	NOUN
ecj-13710	90	3	care	care	NOUN
ecj-13710	90	4	journal	journal	NOUN
ecj-13710	90	5	2025	2025	NUM
ecj-13710	90	6	;	;	PUNCT
ecj-13710	90	7	21:13710	21:13710	NUM
ecj-13710	90	8	]	]	X
ecj-13710	90	9	online	online	ADJ
ecj-13710	90	10	supplementary	supplementary	ADJ
ecj-13710	90	11	materials	material	NOUN
ecj-13710	90	12	table	table	NOUN
ecj-13710	90	13	1	1	NUM
ecj-13710	90	14	.	.	PUNCT
ecj-13710	90	15	changes	change	NOUN
ecj-13710	90	16	in	in	ADP
ecj-13710	90	17	the	the	DET
ecj-13710	90	18	laboratory	laboratory	NOUN
ecj-13710	90	19	values	value	NOUN
ecj-13710	90	20	of	of	ADP
ecj-13710	90	21	the	the	DET
ecj-13710	90	22	patient	patient	NOUN
ecj-13710	90	23	over	over	ADP
ecj-13710	90	24	10	10	NUM
ecj-13710	90	25	postoperative	postoperative	ADJ
ecj-13710	90	26	days	day	NOUN
ecj-13710	90	27	(	(	PUNCT
ecj-13710	90	28	from	from	ADP
ecj-13710	90	29	day	day	NOUN
ecj-13710	90	30	7	7	NUM
ecj-13710	90	31	to	to	ADP
ecj-13710	90	32	day	day	NOUN
ecj-13710	90	33	17	17	NUM
ecj-13710	90	34	)	)	PUNCT
ecj-13710	90	35	.	.	PUNCT
ecj-13710	91	1	"	"	PUNCT
ecj-13710	91	2	n	n	CCONJ
ecj-13710	91	3	/	/	SYM
ecj-13710	91	4	a	a	DET
ecj-13710	91	5	"	"	PUNCT
ecj-13710	91	6	denotes	denote	NOUN
ecj-13710	91	7	that	that	SCONJ
ecj-13710	91	8	the	the	DET
ecj-13710	91	9	laboratory	laboratory	NOUN
ecj-13710	91	10	values	value	NOUN
ecj-13710	91	11	were	be	AUX
ecj-13710	91	12	not	not	PART
ecj-13710	91	13	available	available	ADJ
ecj-13710	91	14	for	for	ADP
ecj-13710	91	15	a	a	DET
ecj-13710	91	16	given	give	VERB
ecj-13710	91	17	day	day	NOUN
ecj-13710	91	18	.	.	PUNCT
ecj-13710	92	1	additionally	additionally	ADV
ecj-13710	92	2	,	,	PUNCT
ecj-13710	92	3	a	a	DET
ecj-13710	92	4	selection	selection	NOUN
ecj-13710	92	5	of	of	ADP
ecj-13710	92	6	the	the	DET
ecj-13710	92	7	patient	patient	NOUN
ecj-13710	92	8	’s	’s	PART
ecj-13710	92	9	in	in	ADP
ecj-13710	92	10	-	-	PUNCT
ecj-13710	92	11	hospital	hospital	NOUN
ecj-13710	92	12	medications	medication	NOUN
ecj-13710	92	13	is	be	AUX
ecj-13710	92	14	documented	document	VERB
ecj-13710	92	15	.	.	PUNCT
ecj-13710	93	1	the	the	DET
ecj-13710	93	2	green	green	ADJ
ecj-13710	93	3	bars	bar	NOUN
ecj-13710	93	4	indicate	indicate	VERB
ecj-13710	93	5	the	the	DET
ecj-13710	93	6	duration	duration	NOUN
ecj-13710	93	7	during	during	ADP
ecj-13710	93	8	which	which	PRON
ecj-13710	93	9	the	the	DET
ecj-13710	93	10	patient	patient	NOUN
ecj-13710	93	11	received	receive	VERB
ecj-13710	93	12	the	the	DET
ecj-13710	93	13	medications	medication	NOUN
ecj-13710	93	14	,	,	PUNCT
ecj-13710	93	15	while	while	SCONJ
ecj-13710	93	16	the	the	DET
ecj-13710	93	17	white	white	ADJ
ecj-13710	93	18	bars	bar	NOUN
ecj-13710	93	19	denote	denote	VERB
ecj-13710	93	20	periods	period	NOUN
ecj-13710	93	21	when	when	SCONJ
ecj-13710	93	22	the	the	DET
ecj-13710	93	23	medications	medication	NOUN
ecj-13710	93	24	were	be	AUX
ecj-13710	93	25	either	either	CCONJ
ecj-13710	93	26	withheld	withhold	VERB
ecj-13710	93	27	or	or	CCONJ
ecj-13710	93	28	discontinued	discontinue	VERB
ecj-13710	93	29	.	.	PUNCT